Multivariate Cluster Analysis of the MMPI-2 and MMPI-2-RF Scales in Spine  Pain Patients with Financial Compensation: Characterization and  Validation of Chronic Pain Subgroups by Aguerrevere, Luis
University of New Orleans 
ScholarWorks@UNO 
University of New Orleans Theses and 
Dissertations Dissertations and Theses 
12-17-2010 
Multivariate Cluster Analysis of the MMPI-2 and MMPI-2-RF 
Scales in Spine Pain Patients with Financial Compensation: 
Characterization and Validation of Chronic Pain Subgroups 
Luis Aguerrevere 
University of New Orleans 
Follow this and additional works at: https://scholarworks.uno.edu/td 
Recommended Citation 
Aguerrevere, Luis, "Multivariate Cluster Analysis of the MMPI-2 and MMPI-2-RF Scales in Spine Pain 
Patients with Financial Compensation: Characterization and Validation of Chronic Pain Subgroups" 
(2010). University of New Orleans Theses and Dissertations. 1267. 
https://scholarworks.uno.edu/td/1267 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by ScholarWorks@UNO 
with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the 
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from 
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself. 
 
This Dissertation has been accepted for inclusion in University of New Orleans Theses and Dissertations by an 
authorized administrator of ScholarWorks@UNO. For more information, please contact scholarworks@uno.edu. 
  
Multivariate Cluster Analysis of the MMPI-2 and MMPI-2-RF Scales in Spine 
Pain Patients with Financial Compensation: Characterization and 
Validation of Chronic Pain Subgroups 
 
 
 
 
A Dissertation 
 
 
 
 
 
Submitted to the Graduate Faculty of the 
University of New Orleans 
in partial fulfillment of the 
requirements for the degree of 
 
 
 
 
 
 
 Doctor of Philosophy 
in 
Applied Biopsychology 
 
 
 
 
 
 
by 
 
Luis E. Aguerrevere 
 
B.S., Tennessee Technological University, 2004 
M.S., University of New Orleans, 2007 
 
December, 2010
ii 
 
 
ACKNOWLEDGMENTS 
 
I would like to express my deepest gratitude to everyone who provided assistance throughout this 
process. To Dr. Greve, for many hours of reading, discussing and advising that he has provided 
throughout my education as well as on this project. To Dr. Bianchini, for his guidance in these 
preliminary stages of my neuropsychological career. You both have been incredible mentors and 
role models. To Dr. Martel, Dr. Weems and Dr. Soignier for their help serving in all my 
committees. To all my family and friends who have offered love and support in the pursuit of all 
my goals. My deepest appreciation to my mother,father, sisters, nephews and niece for their 
never ending support. Your love and patience is always appreciated beyond words. Gracias a 
todos. 
iii 
 
Table of Contents 
LIST OF TABLES ................................................................................................................. V 
LIST OF FIGURES ............................................................................................................ VII 
ABSTRACT ........................................................................................................................ VIII 
INTRODUCTION................................................................................................................... 1 
CHAPTER I ............................................................................................................................ 3 
Pain and Disability ............................................................................................................ 3 
Individual Differences in Pain and Disability ................................................................... 4 
Physical Pathology and Spine Pain .................................................................................. 4 
Psychosocial Factors in Spine Pain .................................................................................. 5 
SUMMARY ............................................................................................................................ 12 
CHAPTER II ......................................................................................................................... 13 
The Minnesota Multiphasic Personality Inventory ......................................................... 13 
The Minnesota Multiphasic Personality Inventory-2 ...................................................... 15 
The Minnesota Multiphasic Personality Invetory-2-Restructured Form ........................ 20 
SUMMARY ............................................................................................................................ 24 
CHAPTER III ....................................................................................................................... 25 
The MMPI and Pain ........................................................................................................ 25 
MMPI Pain Subgroups .................................................................................................... 25 
MMPI-2 Pain Subgroups ................................................................................................. 28 
SUMMARY ............................................................................................................................ 32 
PURPOSE ............................................................................................................................... 33 
CHAPTER IV........................................................................................................................ 35 
METHODS ............................................................................................................................ 35 
PARTICIPANTS ...................................................................................................................... 35 
MEASURES, VARIABLES AND CHARACTERIZATION .............................................................. 36 
ANALYSIS STRATEGY ........................................................................................................... 40 
CHAPTER V ......................................................................................................................... 42 
RESULTS .............................................................................................................................. 42 
Method 1: Traditional Clustering Method ...................................................................... 44 
Method 2: MMPI-2 Clustering Method ........................................................................... 60 
Method 3: MMPI-2-RF Clustering Method .................................................................... 80 
CHAPTER VI...................................................................................................................... 101 
DISCUSSION ...................................................................................................................... 101 
Method 1 ........................................................................................................................ 101 
Method 2 ........................................................................................................................ 102 
Method 3 ........................................................................................................................ 102 
MMPI-2 VS. MMPI-2-RF .................................................................................................. 103 
INTERPRETATION OF PROFILES ........................................................................................... 104 
Triad/Somatic Profile .................................................................................................... 104 
Moderate/Depressed Profiles ........................................................................................ 105 
Pathological Profiles ..................................................................................................... 105 
SUMMARY .......................................................................................................................... 106 
CHAPTER VII .................................................................................................................... 108 
FACTORS RELATED TO SUBGROUP MEMBERSHIP ............................................................... 108 
iv 
 
Injury Severity ............................................................................................................... 108 
Malingering Status ........................................................................................................ 108 
Education and Ethnicity ................................................................................................ 109 
Non Work- Related Claims ............................................................................................ 110 
OUTCOME ........................................................................................................................... 111 
SUMMARY .......................................................................................................................... 112 
CHAPTER VIII .................................................................................................................. 114 
IMPLICATIONS .................................................................................................................... 114 
LIMITATIONS AND FUTURE STUDIES .................................................................................. 115 
CONCLUSION ................................................................................................................... 116 
REFERENCES .................................................................................................................... 117 
APPENDIXES ..................................................................................................................... 129 
APPENDIX A: COMMON PHYSICAL IMPAIRMENTS THAT CAUSE SPINE PAIN ....................... 129 
APPENDIX B:THE PAIN DISABILITY INDEX ......................................................................... 131 
APPENDIX C: PAIN CHATASTROPHIZING SCALE ................................................................. 132 
APPENDIX D: MALINGERING CLASSIFICATION METHOD .................................................... 133 
VITA..................................................................................................................................... 140 
 
 
v 
 
LIST OF TABLES 
Table 1. Minnesota Multiphasic Personality Inventory-2nd edition Scales .…….…………….....17 
Table 2. Minnesota Multiphasic Personality Inventory-2nd edition Restructured Form………..21 
Table 3. T scores at or above  (≥) the interpretative cutoff based on the Lees-Haley et al. (2003) 
MMPI-2 manual.............................................................................................................................37 
Table 4. T scores at or above  (≥) the interpretative cutoff based on the Ben-Porath and Tallegen 
( 2008) MMPI-2-RF  Manualy statistics for the MMPI-2 and MMPI-2-RF variables ............….43 
Table 6. Method 1 MMPI-2 mean, standard deviations, and statistical differences by 
subgroup………………………………………………………………………………………….47 
Table 7. Method 1 percentage of cases that fall above the interpretative cutoff per MMPI-2 
variable……………………………………………………………………..…………………….49 
Table 8. Method 1 MMPI-2-RF mean, standard deviations, and statistical differences by 
subgroup………………………………………………………………………………………….51 
Table 9. Method 1 percentage of Cases that fall above the selected cutoff per MMPI-RF 
variable…...………………………………………………………………………………………53 
Table 10. Method 1 demographic characteristics by subgroup……………………………….....54 
Table 11. Method 1 percentage of patients with specific Injury/Symptom characteristics by pain 
group……………………………………………………………………………………………..55 
Table 12. Method 1 medico-legal characteristics of the chronic pain sample as a function of 
group membership……………………………………………………………………………….56 
Table 13.  Method 1 malingering status by pain group………………………………………….57 
Table 14. Method 1 current, best, worst pain report, PCS and PDI scores as a function of pain 
group…………………………………………………………………………………………….58 
Table 15. Method 2 MMPI-2 scales means and standard deviations by group…………………64 
Table 16. Method 2 percentage of cases that fall above the selected cutoff per subgroup and 
MMPI-2 variable…………………………………………………………………………………67 
Table 17. Method 2 MMPI-2-RF mean, standard deviations, and statistical differences by pain 
group……………………………………………………………………………………………..69 
Table 18. Method 2 percentage of cases that fall above the selected cutoff per group by MMPI-2-
RF variable……………………………………………………………………………………….71 
Table 19. Method 2 demographic characteristics by pain group………………...………………72 
Table 20. Method 2 percentage of patients with specific Injury/Symptom characteristics by pain 
group……………………………………………………………………………………………..73  
Table 21. Method 2 percentage of patients per group by legal status……………………………74 
Table 22. Method 2 malingering status by pain group………………………………………..…76 
Table 23. Method 2 current, best and worst pain, PCS and PDI scores as a function of pain 
group……………………………………………………………………………………………..77 
Table 24. Crosstab on the percentage of cases that overlap between the clustering methods…..84 
Table 25. Method 3 MMPI-2-RF mean, standard deviations, and statistical differences by pain 
subgroup…………………………………………………………………………………………85 
Table 26. Method 3 percentage of Cases that fall above the selected cutoff per MMPI-RF 
variable……………………………………………………………………………………..…….88 
Table 27. MMPI-2 scales means and standard deviations by Method 3 groups…………………90 
vi 
 
Table 28. Method 3 percentage of Cases that fall above the selected cutoff per M1-Pathologicaly 
MMPI-2 variable…………………………………………………………………………………93 
Table 29. Method 3 Demographic characteristics by MMPI-2-RF based subgroups……………94 
Table 30. Percentage of patients with specific Injury/Symptom characteristics by pain group…95 
Table 31. Method 3 medico-legal characteristics of the chronic pain sample as a function of 
Cluster membership…………………………………………………………………...…………96 
Table 32. Method 3 malingering status by pain group………………………………………….97 
Table 33. PCS and PDI scores as a function of pain group……………………………………..98 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
LIST OF FIGURES 
Figure 1. Costello et al., (1987) illustration of cluster solution……………………………..…...27 
Figure 2. Riley et al., (1993) illustration of cluster solution……………………………………..28 
Figure 3. Block and Ohnmeiss (2000) illustration of cluster solution………………………..….31     
Figure 4. Martens et al., (2002) illustration of cluster solution………………………...……..…32      
Figure 5. Method 1 illustration of the profiles of the two subgroups described by all the MMPI-2 
scales…………………………………………………………………………………………….48 
Figure 6. Method 1 illustration of the profiles of the two subgroups described by all the MMPI-2-
RF scales……………………………………………………………………..……………….….52 
Figure 7. Method 2 MMPI-2 profiles for the subgroups that resulted from the two-cluster and the 
three-cluster solutions…………………………………………………………………………....62 
Figure 8 illustrates the subgroup profiles for the Method 2 most comprehensive solution by 
MMPI-2 scales…………………………………………………………………………...………65 
Figure  9.  Method 2 illustration of the profiles of the three-cluster solution described by 
theMMPI-2-RF scales……………………………………………………………………………70 
Figure 10. Method 3 MMPI-2 profiles for the subgroups that resulted from the two-cluster and 
the three-cluster solutions………………………………………………………………………..83 
Figure  11.  Illustration of the profiles of the three subgroups described by the MMPI-2-RF 
scales……………………………………………………………………………………………..86 
Figure  12.  Illustration of the profiles of the three subgroups described by the MMPI-2 scales..91 
 
 
 
 
 
 
 
viii 
 
ABSTRACT 
Different psychosocial factors influence the experience and adaptation to pain. Previous 
cluster analytic studies using the Minnesota Multiphasic Personality Inventory-2nd edition 
described psychologically different subgroups of pain patients that had been shown valuable in 
determining outcome. However, these studies had limited applicability to medico-legal pain 
populations because they did not use newly developed scales or describe important medico-legal 
factors that have large effects on symptom endorsement.  Using three methods of clustering, the 
current investigation explored the subgroups that resulted when using all the MMPI-2 and the 
newly developed MMPI-2-RF (Restructured Form) scales on a large and well-described 
population of medico-legal spine pain patients. Result demonstrated that the best solution for the 
current sample was the two-cluster solution when a traditional method was used. However, the 
best solution was the three-cluster solution when all MMPI-2 scales and a method that used all 
MMPI-2-RF scales were used. Thus, the three-cluster solution was considered the most adequate 
solution to differentiate patients in medico-legal settings. Moreover, results demonstrated that 
subgroup membership was not conditioned to spine related organic factors. Instead, malingering, 
education, ethnic background and legal status differentiated pain subgroups. Lastly, results 
demonstrated a dose-response relationship between perceived outcome and subgroup profile 
elevation. The current results are relevant for understanding the circumstances that can influence 
spine pain recovery and for informing decisions regarding possible interventions. 
Keywords: MMPI-2; MMPI-2-RF; spine pain, disability, psychological overlay, cluster analysis, 
pre-surgical screening, malingering.
1 
INTRODUCTION 
Patients with primary complaints of spine pain often present with a number of symptoms 
and disabilities that result in a great deal of patient’s suffering and economic loss. Although 
spine pain has been typically considered a “medical illness”, the presence of physical pathology 
does not reliably predict levels of pain and disability in the individual patient. As a result, there is 
a growing interest in the role of different psychosocial factors in the experience and adaptation to 
pain. Among these, somatization, emotional distress, and financial compensation are described 
as some of the most important predictors of pain related disability and further examination on 
their role in pain outcome would likely guide interventions.  
The Minnesota Multiphasic Personality Inventory (MMPI) and its second version, the 
MMPI-2, are widely-recognized and reliable measures of psychological problems, including 
somatization and emotional distress. These instruments also contain a number of validity scales 
that are shown to be reliable in identifying manipulation of the patient’s clinical presentation, 
including the identification of those patients that intentionally exaggerate their report to obtain 
significant financial reward (i.e. malingering). Thus, these instruments are often used to both, 
describe the psychological differences among those patients with good and poor pain outcome, 
and distinguish between pain patients with valid profiles and those that exaggerate their report. 
 Previous cluster analytic studies using the MMPI and MMPI-2 traditional validity and 
standard clinical scales describe psychologically different subgroups of pain patients. These 
subgroups have been shown valuable in determining patient response to treatment and in 
decision-making regarding whether to perform surgery. However, there is limited application of 
these results to pain populations where patients are involved in legally compensable events. This 
is because previous studies do not describe important medico-legal factors which may have large 
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effects in symptom endorsement (e.g., injury characteristics, legal representation or malingering 
status) and do not use all the available validity scales.  Using three methods of clustering, the 
current investigation explored the stability of MMPI-2 subgroup solutions in a large and well-
described population of spine pain patients that are involved in legally-compensable processes. 
This investigation also expands previous investigations by adding to the clusters analyses the 
recently developed MMPI-2 validity scales and the MMPI-2 restructured form (MMPI-2-RF) 
clinical (RC) and validity scales. The results from the current investigation are expected to 
increase the clinical application of the MMPI-2 and the MMPI-2-RF in medico-legal pain 
populations. 
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CHAPTER I 
Pain and Disability 
Spine pain, which is pain originating in the back and/or neck, is an extremely prevalent 
condition. The lifetime occurrence of back pain is 11 to 84 percent (Walker, 2000), while neck 
pain occurs in 10 to 15 percent of the population (Hardin & Halla, 1995).  It is estimated that 70 
million Americans experience some form of acute, recurrent, or chronic spine pain each year and 
that 10 percent of the population report the presence of spine pain at least 100 days a year 
(Cassidy, Cote, Carroll, & Kristman, 2005; Covington, 2007). Spine pain complaints result in 
millions of physician office visits per year (Hing, Cherry & Woodwell, 2006), and as many as 
150 million lost work days (Guo, Tanaka, Halperin, & Cameron, 1999). Given its impact it has 
become increasingly important to study the factors that influence pain perception and pain 
related disability.  
In 1979, the International Association for the Study of Pain (IASP) published its first 
working definition of pain : “An unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” (p. 249, Fields, 1987). 
Based on this definition, pain has two functions: It serves as a signal to warn of danger or tissue 
damage; and it compels individuals to avoid worsening the damage, allowing the process of 
restoration of damaged tissues to begin (DeLeo, 2006). However, in some individuals, pain can 
be an extremely debilitating problem as it has been reported to create “suffering” in patients and 
families as its result (Aronoff, 1991).   
Chronic spine pain, especially, has a high impact on the sufferer’s everyday functioning, 
as a range of their activities are often severely limited, leading to difficulties with daily chores, 
social life, and work (Abdel-Moty et al., 1993; Aronoff, 1991; Faucett & McCarthy, 2003; 
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Nurmikko, Nash, & Wiles, 1998).Chronic pain disability is defined as “diminished capacity for 
everyday activities and gainful employment” or the “limitation of a patient’s performance 
compared to a fit person’s of the same demographic characteristics” (e.g. age, gender; p. 24; 
Gatchel, 2006).  The total economic load of chronic pain-related disability in the U.S. is reported 
to exceed $150 billion a year (Gatchel & Okifuji, 2006; Mayer, Gatchel, & Polatin, 2000). Thus, 
determination of the factors that influence chronic spine pain and related outcome is practically 
important for both a patient care and an economical standpoint. 
Individual Differences in Pain and Disability 
There are remarkable individual differences when it comes to perceiving and recovery 
from spine pain. These individual differences are quite understandable when one acknowledges 
that pain and disability are interdependent and complex experiences influenced by multiple 
interactive biopsychosocial processes (Gatchel, Peng, Peters, Fuchs, & Turk, 2007). Especially 
when one considers the multitude of biological and psychosocial factors that increase/decrease 
individual recovery time including vulnerability to nociception, tissue healing, pain 
sensation/report, as well as factors that affect the ability of the individual to cope effectively with 
the challenges faced during recovery (Gatchel et al., 2007). Specifically, pain recovery is 
influenced by a range of pre-and post- injury medical, biological, psychological and social 
factors, which interact with injury, pain perception, and demographic characteristics to modulate 
individual report of symptoms and subsequent disabilities (Gatchel et al., 2008).  
Physical Pathology and Spine Pain 
Physical pathology has important contributions to spine pain and disability (Ochoa, 
2002). For example, herniated nucleus pulposus, foraminal stenosis, and nerve root impingement 
are all associated with pain generation (Burchiel, 2002). Other common spine pathologies that 
5 
 
result in pain include facet joint disorders, vertebral fracture, and musculo-ligamentous injuries 
(see Appendix A for brief descriptions of selected conditions).   
However, in chronic pain only a small proportion of pain perception and disability can be 
attributed to physical pathology (Gatchel, Peng, Peters, Fuchs & Turk, 2007; Gatchel & Okifuji, 
2006; Waddell, Pilowsky, & Bond, 1989; Tait, 1990). Also, nearly 40% of chronic pain patients 
seen in primary care clinics do not benefit from traditional pain/surgical procedures suggesting 
that modification of the physical pathology does not always alleviate pain/disability (Block et al., 
2003). Thus, in an important number of chronic pain patients, pathophysiology does not have a 
direct causal relationship with pain perception/disability, nor does it reliably predict who will 
have pain in the future.  
Psychosocial Factors in Spine Pain 
Recent research has implicated that a number of psychosocial factors are related to poor 
pain outcome, especially in the transition between acute and chronic pain. The following sections 
discuss the impact of somatization, emotional distress, and financial incentive on individual 
differences of spine pain symptomatology and recovery. These psychosocial factors were 
selected for review because they are often assessed in comprehensive psychological pain 
evaluations.  
Somatization 
Somatization, and related terms (e.g. somatoform disorder), is a central factor in 
understanding pain and disability attributed to pain (Allen, Gara, Escobar, Waitzkin, & Silver, 
2001; Lamberty, 2008). Somatization refers to the way “certain patients use their physical 
symptoms as a way of dealing with, and communicating about, their emotional lives . . . in this 
type of symptom magnification, physical symptoms may be easier to accept as causing current 
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unhappiness and discontent than admitting that some psychological reason is contributing to it” 
(Gatchel, 2004; p. 204). In other words, somatization is the expression of psychological 
problems or stress manifested in physical symptoms and complaints. 
Several empirical and review studies demonstrate that patients with high levels of 
measured somatization report higher levels of pain perception and significant disabilities in  
daily chores, social life, and work (e.g., Bacon et al., 1994; Birket-Smith, 2001; Shorter, 1997). 
Furthermore, high levels of somatization are found to predict greater perceived disability one 
year after the injury above and beyond injury characteristics (Gatchel, Polantin, Mayer & Garcy, 
1994), and are likely to  have poor response to surgery and conservative care (Block, 
Vanharanta, Ohnmeiss, & Guyer, 1996).This demonstrates that somatization is not a pure 
physiological phenomenon, but is a result of the psychological mechanisms of pain. In short, 
somatization may be viewed as a potentially maladaptive trait or coping style that contributes to 
excess pain symptoms and pain-related disability. 
Emotional distress 
People who experience chronic pain also experience a wide variety of associated 
emotions (Gaskin, Greene, Robinson, & Geisser, 1992). The most common emotional problems 
are depression and anxiety disorders, which occur in 30% to 84% and 14 to 40% of chronic pain 
patients, respectively (Arnow et al., 2006; Aguera, Failde, Cervilla, Diaz-Fernandez & Mico, 
2010; Gaskin, Greene, Robinson & Geisser, 1992; Manchikanti et al., 2002). 
A number of studies reveal a significant relationship between self-reported pain intensity 
and depressive symptoms (Carleton, Abrams, Kachur & Asmundson; Hoff, Palermo, Schluchter, 
Zebracki & Drotar, 2006; Weijenborg, Ter Kuile, Gopie & Spinhoven, 2009). Levels of 
depression are recognized to have a direct relation to nociception and inverse relation to tissue 
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recovery (Gur et al., 2002). Moreover, patients with high numbers of helplessness behaviors and 
catastrophizing thoughts - key elements of depression - also report significantly more pain than 
other patients with similar injury characteristics but fewer depression symptoms (Arnow et al., 
2006; Bair et al., 2008; Borsbo et al., 2008;  Geisser et al., 1994; Roth, Lowery & Hamill, 2004). 
In an important study, Holzberg, Robinson, Geisser, and Gremillion (1996) demonstrated that 
self- reported disability was directly influenced by levels of depression, whereas pain levels did 
not have a direct effect on self-report of function.   
It is also common for patients with pain to be anxious and worried. People with chronic 
pain may be anxious about the meaning of their symptoms and for their futures (Gatchel, 2004). 
People with pain also experience anxiety about partaking in activities that may exacerbate their 
symptoms (Bair et al., 2008). Clinical levels of anxiety may significantly increase the perceived 
intensity of painful stimuli by directly impacting the physiological aspects that contribute to pain 
perception (Colloca & Benedetti, 2007). Excessive anxiety may also negatively impact outcome 
during treatment or following surgery by increasing avoidance behaviors, as higher level of 
anxiety is associated with lack of cooperation during rehabilitation sessions and hypervigilance 
to the occurrence of pain (Robb, Williams, Duvivier & Newham, 2006; Vadalouca et al., 2009; 
Velanovich, 2006). 
Levels of catastrophization 
Patients’ overestimation of the association between physical symptoms and negative 
outcomes (i.e. catastrophization ) is central to most models of poor outcome after pain injury 
(Severeijns, Vlaeyen, van den Hout, & Weber, 2001). Catastrophizing is a cognitive process that 
refers to a tendency to emphasize and exaggerate the negative appraisal of current or future 
situations (Sullivan & D'Eon, 1990). Pain catastrophizing has been shown to be a mediator of the 
relationship between negative emotions and illness behaviors and recovery, which suggest  that 
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catastrophizing is the core determinant of entering into a negative pain-disability cycle  (Lackner 
& Quigley, 2005). Factor analytic studies have revealed three primary components of pain 
catastrophizing: magnification, rumination, and helplessness (Van Damme, Crombez, Bijttebier, 
Goubert, & Van Houdenhove, 2002).  
The evidence for the role of catastrophization and its components in outcome after 
painful injuries is overwhelming and has been summarized in several reviews (Block & Brock, 
2008; Jensen, Turner, & Romano, 2001; Leeuw et al., 2007). Cross-sectional studies across 
clinical and non-clinical populations have demonstrated that subjects with high levels of 
catastrophization show increased pain, lower treatment benefits, and physical and psychological 
dysfunctions ( Epker & Block, 2001; Edwards, Smith, Stonerock, & Haythornthwaite, 2006; 
Martorella, Cote, & Choiniere, 2008; Turner, Jensen, Warms, & Cardenas, 2002). Prospective 
studies indicated that levels of catastrophization may predict the development of chronic 
musculoskeletal pain in the general population ( Myers et al., 2008) and of more intense pain and 
slower recovery after a spine injury and surgical interventions (Granot & Lavee, 2005; Block et 
al., 2008). Catastrophization has also been shown to be a significant predictor of illness 
behaviors, a core component of disability, despite some overlap with emotional distress (Sullivan 
et al., 1990).There is evidence that pain catastrophization is a precursor to the development of 
pain-related fear (Leeuw et al., 2007).Moreover, several studies have shown that cognitive 
restructuring therapy for catastrophization can reduce pain intensity and improve pain outcome ( 
Hanley, Raichle, Jensen & Cardenas, 2008). Thus, levels and treatment of catastrophization have 
shown to be key elements in individual recovery from painful injuries. 
Pre or Post Morbid Debate 
 Although the existence of diagnosable psychological overlay among those patients with 
poor pain outcome is certain, the etiology of such problem is controversial (Gamsa, 1990). Some 
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researchers have argued that psychological disturbances are primarily a reaction to the injury and 
pain (Gamsa, 1994). This is  supported by early studies that reported an increase in emotional 
distress after an injury (Gamsa & Vikis-Freibergs, 1991) and studies that reported that treatment-
related pain relief is accompanied by a reduction in emotional difficulty (Snow, Gusmorino, 
Pinter, Jimenez, & Rosenblum, 1988; Stein, Peri, Edelstein, Elizur & Floman, 1996).  
Psychological problems are also theorized to predispose patients to have poor outcome 
after a painful injury. This is supported by longitudinal studies reporting that individuals with 
documented pre- injury depressive emotions and anxiety tend to interpret a given sensation as 
painful and are prone to develop pain problems (for review see, Gatchel, Polantin & Mayer, 
1995). For example, Bigos, Battie and Fisher (1991) found that individuals with high levels of 
depression were at a significantly higher risk of developing occupational back complaints over a 
four year period compared to those without such elevations. Holzberg, Robinson, Geisser and 
Gremillion (1994) also found that pre-injury anxiety and depression were included among the 
factors  that have the most important influence, above and beyond physical abnormalities, of 
future pain and pain-outcome.  
Further, several studies have demonstrated that patients that report a number of 
psychological problems preceding spine injury have poorer reaction to spine surgery (for review 
see Block, 1996 and Block, 2002). Block, Ohnmeiss, Guyer, Rashbaum and Hochschuler  (2001) 
also found that psychological treatment prior to the spine injury contributed significantly to 
reduce surgical outcome. In summary, whether pre or post-injury, emotional stability is an 
essential part of recovery from spine pain. Therefore, measuring distress very likely helps the 
determination of patients that are “at risk” for poor pain recovery by pointing out the origin of 
symptoms and disabilities, as well as potential treatment effectiveness.  
10 
 
Compensation 
Patients who are in pain have many reasons to seek legal recourse (Hing, Cherry & 
Woodwell, 2006). Often pain make patients unable to work or significantly decreases their 
ability to function in their jobs (Guo et al., 1995; Guo, Tanaka, Halperin, & Cameron, 
1999).Social security disability benefits, workers’ compensation and/or litigation may be the 
only way to regain some of their lost income. In fact, spine pain is the most common reason for 
filing a workers’ compensation claim (Guo et al., 1999). 
Compensation settings are often complex and stressful psychosocial environments which 
may aggravate pain problems. In general, patients seen in financially-compensatory contexts 
report significantly more pain, depression, disability, as well as a decreased treatment efficacy 
and productivity (Harris et al., 2005; Rainville, Sobel, Hartigan, Monlux & Bean, 1997; Rohling, 
Binder, & Langhinrichsen-Rohling, 1995; Vaccaro, Ring, Scuderi, Cohen, & Garfin, 1997) even 
when compared to patients with similar spine pathologies who are not in financially 
compensatory contexts (Atlas et al., 2000 & Atlas et al., 2006). 
 There are several factors from which compensation (or the process of getting 
compensated) can negatively impact outcome (Teasell, 2001). Workplace-relate factors, such a 
blaming the employer for the injury, job dissatisfaction, and occupational stress have been 
reported to negatively influence recovery (Guo, 2002; Hagen et al., 2002; Menzel, 2007; Shaw et 
al., 2005). Delays of treatment caused by workers’ compensation regulations can also increase 
the extent of the injury or the time required  for recovery (Rich, 2008). Moreover, financial stress 
caused by the injury can divert the patient’s focus away from rehabilitation efforts and instead 
place it on economic survival (Ballamy, 1997).  
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Malingering 
 However, there is evidence that at least some of the negative relationship between 
compensation and outcome is due to patients’ intentional exaggeration of symptoms and 
disabilities. Important base rate studies report a sizeable minority of compensable pain patients 
(20% to 50%) intentionally exaggerate their clinical presentation in order to obtain significant 
monetary reward (i.e. malingering; Greve, Ord, Bianchini & Curtis, 2009; Mittenberg et al 
2002). These rates are consistent among different compensated populations such as social 
security disability evaluations (Chafetz, 2008), toxic exposure (Greve, Bianchini, Black et al., 
2006), and traumatic brain injury (Larrabee, 2003). Thus suggesting that malingering in medico-
legal settings is not a rare phenomenon and should be taken into consideration. 
Malingering becomes a problem when determining proper intervention as it can 
potentially lead to inaccurate conclusions regarding the patient’s status. As such, researchers 
have developed ways to better identify those that are malingering.  One such classification 
method that has been recently developed is the Malingering Pain Related Disability criteria 
(MPRD; Bianchini, Greve & Glynn, 2005). MPRD is defined as “the intentional exaggeration or 
fabrication of cognitive, emotional, behavioral, or physical dysfunction attributed to pain for the 
purposes of obtaining financial gain, to avoid work, or to obtain drugs (Bianchini, et al., 2005). 
There are three key points of the criteria; first, is that malingerers intentionally over report 
symptoms and disabilities due to external incentives; second, is that malingerers may present 
symptoms and/or impairments in multiple ways and; third,  malingering relates not only to 
symptoms but also to the disability that is attributed to the pain (Bianchini et al., 2005). Thus, 
Bianchini et al. (2005) suggest that when determining that a specific subject is malingering one 
requires to evaluate “intent” in a comprehensive manner by considering multiple, highly 
improbable events (e.g. symptoms, disabilities, behaviors).  Therefore, using the Bianchini et al. 
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(2005) MPRD criteria to identify or rule out malingering in both clinical or research settings 
would likely maximize confidence that results of psychological measures, diagnoses, and 
recommendations are based on the legitimate problems/concerns of the pain patient. 
Summary 
Spine pain and disability affect, and are affected by, multiple interactive biomedical and 
psychosocial factors. In the psychosocial area, somatization, chatasthrophization, emotional 
distress, and financial compensation have proven to negatively impact recovery. Malingering 
must also be taken into consideration, as an important number of compensated pain patients 
exaggerate their symptom and disability reports to obtain financial awards. Thus, it is important 
to have reliable measures that can help identify the individual problems or concerns of the pain 
patient while considering altered patient symptom presentation. Reliable assessment of 
psychosocial factors of pain could potentially help determine the best possible intervention for 
the individual patient as well as to help cut enormous costs involved in medico-legal pain 
management approaches. 
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CHAPTER II 
The Minnesota Multiphasic Personality Inventory 
The Minnesota Multiphasic Personality Inventory (MMPI; Hathaway & McKinley, 1943) 
and its revision: The Minnesota Multiphasic Personality Inventory-second edition (MMPI-2; 
Butcher, Dahlstrom, Graham, Tallegen & Kraemmer, 1989), are the most widely-used measures 
to study psychological disturbances including somatization, depression, and anxiety in pain 
settings and other health areas (Keller & Butcher, 1991; Rabin, Barr & Burton, 2005). The 
widespread use of the original MMPI and MMPI-2 in these settings is attributable to several 
factors, including their simplicity of scoring and administration, an objective response format 
important for research designs, manuals with useful applications, and thousands of empirically-
established investigations (for review see; Butcher & William, 2000; Friedman, Lewak, Nichols 
& Webb, 2001; Graham, 2006).  
Original MMPI 
The original MMPI consists in 566- true- false items which result in three traditional 
validity scales and ten standard clinical scales (Hathaway & McKinley, 1943). The validity 
scales were included in the original MMPI to assist in recognizing test records produced by 
uncooperative or deceptive participants with different test-taking attitudes (e.g. under-reporting 
or over-reporting of symptoms) or participants who have difficulty comprehending the test items. 
The clinical scales were developed primarily to assist in determining the type and severity of 
psychiatric conditions. A secondary goal of the standard clinical scales was to provide an 
objective means of estimating therapeutic effects and other changes in the status of patient’s 
conditions across time (Dahlstrom, Welsh, & Dalstrom, 1972; Keller & Butcher, 1991).  
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Traditional Validity Scales 
The traditional validity scales created by Hathaway and McKinley (1943) in the original 
MMPI are: the Cannot Say score, the L (Lie) scale, the F (Infrequency) scale, and the K 
(Correction) scale. The Cannot Say score is the number of items that either are omitted or are 
answered as both true and false. It is important to assess the Cannot Say score because omission 
of many items will invalidate the test. The L scale was designed to spot individuals who present 
in overly favorable way (Meehl & Hathaway, 1946). Patients who have a high L score may have 
difficulty admitting even minor flaws. The F scale was designed to recognize unusual, deviant, 
and atypical ways of approaching the MMPI test items (Meehl & Hathaway, 1946). Graham 
(1993) described three important functions of the F scale: 1) recognizing abnormal test-taking 
sets; 2) gauging the severity of psychopathology; and 3) suggesting other clinically-relevant 
information about an individual. The K scale was developed to detect individuals who attempt to 
portray themselves in either an overly favorable or unfavorable manner (Meehl & Hathaway, 
1946). Elevated scores can suggest defensiveness; lower scores can suggest a perceive inability 
to manage difficult circumstances (Graham, 1993). 
Some MMPI users consider a protocol invalid or non-interpretable if it has more than 30 
omitted items or has a T score greater than 70 on Scales L and K (Graham, 1993). For Scale F, 
score at or above 90 increases the possibility of an invalidating response set due to symptom 
over-reporting. However, scores at or above this level in Scale F could also suggest serious 
psychopathology (Graham, 1993). 
Standard Clinical Scales 
Since the MMPI’s publication, hundreds of studies have examined the relationship 
between the clinical scales and relevant extra-test characteristics, such as symptoms personality 
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traits, diagnosis, and response to treatment. These studies were conducted in a variety of 
nonclinical, mental health, and correctional settings (for a comprehensive review see, Butcher, 
1989).The gathered results suggest that the MMPI clinical scales are meaningfully related to 
conceptually relevant extra-test characteristics. For example, individuals with elevated scores in 
Scale 1 (Hypochondriasis) often demonstrate somatic concerns, somatic symptoms, and 
undefined complains, such as gastric upset, fatigue, pain, and physical weakness. High scorers on 
Scale 2 (Depression) are seen as depressed, unhappy, dysphonic, pessimistic, and sluggish. 
Individual who score high on Scale 3 (Hysteria) tend to react to stress by developing physical 
symptoms such as headaches, chest pains, weakness and tachycardia. These individuals 
sometimes develop physical problems in reaction to stress (Graham, 1993). Classically, 
elevations on Scales 1 and 3 have been ascribed to somatization (Block et al, 2003; Blumetti & 
Modesti, 1976; Friedman, Gleser, Smeltzer, Wakefield, & Schwartz, 1983; Marks & Seeman, 
1963), while Scales 2 and 7 have been linked to depression and anxiety, respectively (Graham, 
2006).    
In general, clinical scales with T scores equal or greater than 70 are considered clinically-
elevated in the original MMPI. However, higher scores are associated with more severe 
symptoms and problems (e.g. depression for Scale 2). A study by Graham, Ben-Porath, Forbey, 
and Sellbom (2003) using the MMPI-2 supported this notion. Patients with very high scores on 
the clinical scales had more severe symptoms and problems than those with moderately high 
scores. 
The Minnesota Multiphasic Personality Inventory-2 
In 1989, the original MMPI was revised into the MMPI-2. One goal of the MMPI-2 was 
to preserve the established original MMPI clinical correlates while expanding the item pool to 
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cover additional areas (Butcher, et al., 1989; Keller & Butcher, 1991). Items that had 
objectionable content were removed or rewritten. New items were added to cover content areas 
that were underrepresented in the original MMPI. In its final form, the MMPI-2 has 567 items 
and item membership of the traditional validity (L, F and K) and standard scales (1-0) are largely 
equivalent to the original MMPI (Butcher et al., 1989).  As discussed by Keller and Butcher 
(1991), the largest difference between the MMPI and the MMPI-2 are likely result from 
differences in norming procedures. The other major difference is that the scores for standard 
clinical scales were considered elevated at or above T score 65, instead of 70 (Keller & Butcher, 
1991).Validity scales are generally considered elevated at or above T score 75 (Graham, 2006). 
Although the MMPI-2 has not been revised since its publication in 1989, several 
developments should be noted. New scales were created to determine inconsistent responding, 
and under- or over- reporting of symptoms (discussed below; Graham, 2006). Another recent 
development after the publication of the MMPI-2 is the development of the Restructured Clinical 
(RC) scales (Tallegen et al., 2003) and the RF validity scales, which now comprise the compose 
Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF; Tallegen & 
Ben-Porath, 2008). For a description of all validity and clinical scales refer to Table 
1.Descriptions and discussion of these new scales is presented next.  
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Table 1  
Minnesota Multiphasic Personality Inventory-2nd edition Scales 
Validity Scales   
F 
Infrequency Infrequent responses in the general population first half of the test 
Fb Infrequency back 
Infrequent responses in the general population 
second half of the test 
Fp 
Infrequency 
psychopathology Infrequent responses in psychiatric population 
FBS 
Symptom Validity 
Scale Non-credible somatic and cognitive complains 
L Lie Uncommon virtues 
K 
Correction Uncommonly high levels of psychological adjustment 
S Self-Presentation Defensiveness presentation 
Clinical Scales 
1 
Hypochondriasis Somatic concerns, somatic symptoms, and undefined complains 
2 
Depression Depressed, unhappy, dysphonic, pessimistic, and sluggish. 
3 
Hysteria Reaction to stress by developing physical symptoms 
4 Psychopathic Deviate Antisocial behavior, rebellious attitudes. 
5 Masculinity-Femininity Gender interests 
6 
Paranoia Reactions of others, suspicious and guarded, and are hostile, resentful, and argumentative 
7 Psychasthenia Tend to be anxious, tense and agitated 
8 
Schizophrenia Psychotic behaviors, confusion, disorganization, and disorientation. 
9 
Hypomania 
Hyperactive and/or have accelerated speech 
and may have hallucinations or delusions of 
grandeur 
0 
Social Introversion Social introversion and low scores reflect social extroversion 
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MMPI-2 New Validity Scales 
Inconsistent reporting Scales. Validity Response Inconsistency (VRIN; Butcher, 1989, 
2001) was developed for the MMPI-2 as an additional validity indicator. It provides an 
indication of a tendency to respond inconsistently to MMPI-2 items. The MMPI-2 manual 
(Butcher, 1989, 2001) suggests that a T ≥ 80 indicates inconsistent responding that invalidates 
the resulting protocol.True Response Inconsistency (TRIN; Butcher, 1989, 2001) was developed 
for the MMPI-2 to identify persons who respond inconsistently to items giving true responses to 
items indiscriminately (acquiescence) or by giving false responses to items indiscriminately 
(non-acquiescence). The MMPI-2 manual also suggests that TRIN scale of T ≥ 80 indicates 
inconsistent responding that invalidates the resulting protocol. Subsequent to the publication of 
the MMPI-2, several empirical studies have confirmed that VRIN and TRIN scale are sensitive 
to random responding (Archer, Fontaine, & McCrae, 1998; Greiffenstein, Baker, Tsushima, 
Bonne, & Fox, 2010; Lees-Haley, 1997; Pinsoneault, 2007). 
Under Reporting or Defensiveness. Butcher and Han (1995) developed the Superlative 
Self Presentation (Scale S) to assess the tendency of some persons to present themselves on the 
MMPI-2 as high virtuous, responsible individuals, who are free of psychological problems, have 
few or no moral flaws, and get along extremely well with others. Butcher and Han (1995) 
reported that there are five major content dimensions in the S scale items: 1) belief in human 
goodness; 2) serenity, 3) contentment with life; 4) patient and denial of irritability and anger; and 
5) denial of moral flaws. Higher Scale S scorers in the MMPI-2 are reported to be unrealistically 
reporting positive attributes and good adjustment (Archer, Handel & Couvadelli, 2004; Butcher 
& Han, 1995; Baer & Wetter, 1997; Baer & Miller, 2002).  
Over-reporting. With the introduction of the MMPI-2 it was recognized that the 
traditional Scale F is based on items that occur early in the booklet; thus, it did not assess the 
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validity of items that appeared later in the booklet. Scale Infrequency Back (Fb; Butcher et al., 
1989, 2002) was developed to determine the validity of items appearing after item 350. Elevated 
Scale Fb score could indicate that the test taker responded to items in the second half of the test 
booklet in an invalid manner. It was also recognized in some clinical settings that high scores on 
Scale F are often due, or at least in part, to severe psychopathology of those who take the MMPI-
2.Thus, Arbisi & Ben-Porath (1995) developed the Infrequency Psychopathology (Fp) scale as 
supplement to the Scale F in identifying infrequent psychiatric responding. The 27 items in Scale 
Fp are ones that were answered infrequently by both psychiatric inpatients and persons in the 
MMPI-2 normative sample. The resulting Scale Fp is less likely to reflect psychopathology than 
the Scale F items (Archer, Handel, Greene, Baer & Elkins, 2001).   
Specifically for personal injury claimants, Lees-Haley, English, and Glenn (1991) 
developed the Symptom Validity Scale (FBS) to detect invalid responding of emotional distress. 
FBS is probably the best studied and validated scale across a range of medical and psychological 
conditions (For reviews see, Greiffenstein, Fox, & Lees-Haley, 2006; Nelson, Sweet, & 
Demakis, 2006 ). FBS is sensitive to a response set that is goal directed and designed to:1) 
appear psychologically normal except for the influence of the alleged injury; 2) minimize pre-
injury psychopathology;  and 3) appear honest and present a plausible degree of injury or 
disability (Larrabee, 1998). 
The over-reporting validity scales (including Scale F) of the MMPI-2 are effective in 
identifying persons who intentionally exaggerate their symptoms (for reviews see in particular 
Rogers, Sewell, Martin, & Vitacco, 2003, and Lees-Haley, Iverson, Lange, Fox, & Allen, 2003). 
The MMPI-2 validity scales have been shown effective in differentiating non-clinical 
individuals, typically college students, who took the test under standard instructions from those 
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instructed to malinger (simulators; e.g., Berry et al., 1996). Later studies have also demonstrated 
that the over-reporting validity scales can differentiate known-malingerers from other types of 
responding. Larrabee (2003), Greve et al. (2006), and Bianchini et al. (2008), for instance, used a 
criterion validation (or known groups) design to determine the classification accuracy of a 
number of MMPI-2 validity scales and indicators in the detection of cognitive malingering in 
traumatic brain injury (TBI) and pain-related disability (PRD), and demonstrated the ability of 
these scales to accurately differentiate non-malingerers from malingerers.  Note that the above 
studies involved patients with similar levels of physical pathology suggesting that differences in 
malingering classification explained the differences in MMPI-2 scores. 
 The Minnesota Multiphasic Personality Invetory-2-Restructured Form 
The Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF; 
Tellegen & Ben-Porath, 2008) is now offered as alternative to the MMPI-2. The MMPI-2-RF 
was developed to be a less time-consuming update of the MMPI-2 (Tellegen & Ben-Porath, 
2008). The restructured form consists of 338 items. The MMPI-2-RF has no new or changed 
items, nor has it been re-standardized. Instead, the original standardization sample from the 
MMPI-2 was used to construct or restructure 50 new and revised scales, with the Restructured 
Clinical (RC) and the restructured validity scales at the core. See Table 2 for a detailed 
description of the RC and RF validity scales. 
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Table 2  
Minnesota Multiphasic Personality Inventory-2nd edition Restructured Form 
Restructured Form Validity Scales   
F-r Infrequency restructured Infrequent responses in the general population 
 
Fp-r 
 
Infrequency 
psychopathology  
restructured 
 
 
Infrequent responses in psychiatric population 
Fs Infrequency somatic symptoms 
 
infrequent somatic complains in medical 
patient population 
FBS-r Symptom Validity Scale Non-credible somatic and cognitive complains
L-r Lie Uncommon virtues 
K-r Correction 
Uncommonly high levels of psychological 
adjustment 
Restructured Clinical Scales   
RCd Demoralization 
General dissatisfaction, unhappiness, 
hopelessness, self doubt, inefficacy 
RC1 Somatic Complains 
Self-reported neurological, gastrointestinal, 
and pain related complains 
RC2 Low Positive Emotions 
Lack of, or incapacity to experience  positive 
emotions. Core vulnerability factor for 
depression 
RC3 Cynism Non-self-referential belief in human badness 
RC4 Antisocial Behavior 
Including, juvenile misconduct, family 
problems, substance misuse 
RC6 Ideas of Persecution Self-referential persecutory ideation 
RC7 
 
Dysfunctional Negative    
Emotions 
Including, anxiety, irritability, anger, over-
sensitivity, vulnerability 
RC8 Aberrant Experiences Unusual perceptual and thought processes 
RC9 Hypomanic Activation 
impulsivity, grandiosity, aggression, and 
generalize activation 
 
Restructured Scales 
There are nine restructured clinical (RC) scales, all of which are derived from selective 
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items included in the standard clinical scales. Tallegen et al., (2003) report that the RC scales for 
the MMPI-2 were constructed to “preserve the important descriptive properties of the existing 
MMPI-2 clinical scales while enhancing their distinctiveness” (p. 10).Initially, the authors 
identified and separated items from the clinical scales that detected a “general complaint or 
malaise factor (i.e. demoralization)” (p.11), and created a single scale, RCd, to separate this 
nonspecific factor that seems to pervade throughout the original clinical scales. The remaining 
RC scales correspond roughly with the numerical order of the MMPI-2 traditional clinical scales 
(e.g. RC1 is the updated version of scale 1, Hysteria). The profile includes the Demoralization 
scale (RCd), the Somatic Complains scale (RC1), the Low Positive Emotions scale (RC2), the 
Cynism scale (RC3), the Antisocial Behavior scale (RC4), the Ideas of Persecution scale (RC6), 
the Dysfunctional Negative Emotions scale (RC7), the Aberrant Experiences scale (RC8), and 
the Hypomanic Activation scale (RC9). Standard clinical Scale 5 (Masculinity-Feminity) and 
Scale 0 (Social Inhibition) are not represented in the RC scales profile (Tallegen et al., 2003). 
When comparing reliability and validity of the RC scales with the clinical scales, RC 
scales have demonstrated lower intercorrelations, increased reliability, and less saturation with 
demoralization (Tallegen et al., 2003). The RC scales also show markedly-refined discriminant 
validity and proportional, and in some cases significantly improved, convergent validity than the 
standard clinical scales (Arbisi, Sellbom, & Ben-Porath, 2008; Ben-Porath & Tallegen, 2008; 
Forbey & Ben-Porath, 2008; Osberg, Haseley, & Kamas, 2008; Tallegen et al., 2003). In a 
comparison study, Sellbom, Ben-Portah, McNulty, Arbisi, and Graham (2006) examined the 
frequency, origins, and interpretative implications of elevation differences between the RC scales 
and the standard clinical scales. Analyzing data from mental health inpatients and outpatients, 
they found that the RC scale and its original counterpart will more often agree than disagree as a 
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dichotomous variables (i.e. elevated v. not elevated score). When differences did occur, they 
were attributable in the vast majority to some combination of demoralization, the K-correction, 
and subtle items to scores on the standard clinical scales. With respect to interpretative 
implications of these differences, Sellbom et al., (2006) described that in cases where the 
standard clinical scale is elevated but its RC counterpart was not, the patient was less likely to 
present a the specific psychological problem in collateral information . Conversely, when an RC 
scale was elevated and its original counterpart was not, the patient was most likely to present the 
psychopathology in collateral data. 
Reformed Validity 
The MMPI-2-RF includes eight validity indicators, revised versions of the MMPI-2 
Response Inconsitency (VRIN-r) and True Response Inconsistency (TRIN-r) scales, Uncommon 
Virtues (L-r) and the Correction scale, now labeled Adjustment Validity (K-r). The MMPI-2-RF 
also has four over-reporting indicators: the Infrequent Responses (F-r) scale serves as a general 
over-reporting indicator and is comprised of 32 items rarely endorsed by the MMPI-2-RF 
normative sample. Unlike the MMPI-2 F scale, which was developed with the original MMPI, F-
r is more similar to the Fb scale of the MMPI-2, which is composed of items infrequently 
endorsed in 1989 normative sample.  
The Infrequent Psychopathology Responses (Fp-r) scale is the MMPI-2-RF indicator of 
over-reported symptoms of severe psychopathology. Fp-r is shorter than its counterpart the 
MMPI Fp, consisting of 21 items. A revised version of the Symptom Validity (FBS-r) scale is 
the same as its counterpart MMPI-2 FBS, and assesses non-credible somatic and neurocognitive 
complains. Finally, Somatic Response (Fs) was added to the MMPI-2-RF to measure over-
reporting of somatic complains using the traditional infrequency approach. Wygant, Ben-Porath, 
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and Arbisi (2004) developed Fs by identifying 16 items with somatic content that were endorsed 
by less than 25% of patients in two large archival medical samples and an archival chronic pain 
sample.  
To this end, only one study (Wygant, Ben-Porath, Arbisi et al., 2009) has specifically 
used the MMPI-2-RF validity scales to differentiate intentional symptom over reporting from 
other types of symptom report in financially-compensated settings. Wygant, et al., (2009) 
examined the MMPI-2-RF scores of 151 personal injury and disability claimants. Out of these, 
16% experienced painful injuries. Wygant and colleagues found that all four MMPI-2-RF over-
reporting validity scales were useful in detecting simulated and known intentional symptom 
exaggeration. Specifically, these authors demonstrated all validity scales reliably differentiate 
criterion-determined malingerers from not-malingering. 
Summary 
The MMPI and the MMPI-2 are widely recognized and reliable measures of 
psychological problems and alterations in patient’s clinical presentation. These measures 
traditionally contained three validity scales (L, F, and K) and ten clinical scales (1-0). With (and 
after) the introduction of the MMPI-2 new scales have been developed, including scales that 
measure misinterpretation of test (VRIN and TRIN),  under-reporting (S) and over-reporting (Fb, 
Fp and FBS) of symptoms. Moreover, shorter and divergent clinical (RC) and validity (RF 
validity) were recently developed to minimize completion time as well as to reduce scale 
overlap. The use of the MMPI variables have helped clarify how psychological overlay 
influences pain perception and pain related outcome.  Research on the MMPI in pain is presented 
in the next chapter. 
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CHAPTER III 
The MMPI and Pain 
The MMPI and MMPI-2 have been frequently and extensively used in the assessment of 
patients with pain (Keller & Butcher, 1991; Snyder, 1990; Vendrig, 2000). These instruments 
have been used to describe the characteristics of the typical pain patient (Costello, Hulsey, 
Schoenfeld & Rammamurty, 1987; Keller and Butcher, 1991; Block, Gatchel, Deardoff & 
Guyer, 2004) and to determine differences among those patients that recover from those that do 
not recover to pre-injury levels (for review see Robinson, 2000 and Deardorff, 2000). Such 
descriptions and determinations have been demonstrated to have relevance for a) disclosing 
etiologic factors in chronic pain stages, b) guiding clinicians in development general treatment 
programs, and c) predicting the development of pain problems (Butcher & Rouse, 1996; Gatchel, 
2008; Block, et al., 2004). 
MMPI Pain Subgroups 
 One important contribution of the MMPI research in pain is the description of subgroups 
that differ significantly in psychological characteristics and pain-related outcome. Sternbach 
(1978) originally proposed the existence of four homogeneous and distinctive pain subgroups  
based on clinical appreciation profiles on the original MMPI. The patients in the first group 
reported elevations on scales 1, 2, and 3, with scale 2 being the highest. This subgroup was 
described as “depressive” because patients tended to be dissatisfied with their condition or 
situation. The next group reported equal elevations on scales 1, 2 and 3. These patients were 
categorized as “hypochondriacs” as patients were consumed by somatic concerns. A third group 
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demonstrated a profile with medium elevations only on scales 1, 3 but not on Scale 2.These 
patients were characterized as “Conversion V” and they did not present any particular 
psychopathology. The “manipulative reactions” group was the last profile and was characterized 
by multiple scale elevations, especially on Scale 4. These patients tended to be “game-player 
manipulators” (p.330) and were thought to use the services of health care professionals for 
secondary gain. 
Subsequently, Sternbach’s ideas were tested using cluster analysis1, a more objective or 
empirical method of group classification. For example, Bradley and colleagues (Bradley et al., 
1981) used hierarchical agglomerative cluster analysis on all the original MMPI scales and found 
a four-cluster solution for females and three-cluster solution for males. In both sexes, a subgroup 
with elevations on scales 1, 2, and 3 was common. A second common subgroup in both sexes 
was one that had all scales within normal limits, although borderline elevations or less than two 
standard deviations above the mean were obtained on scales K, 1 and 3. A third but less 
frequently seen pattern in both sexes was multiple scale (four or more) elevations. Finally, in 
women only, a group was found having elevations on scales 1 and 3 but not on scale 2.  
McGill, Lawlis, Selby, Mooney, and McCoy (1983) confirmed these results examining 
92 patients in an inpatient program for treatment of low back pain. The investigators reported 
that they replicated the clusters solution that Bradley et al., (1983) found for men and women 
alike. Moreover, the profile subgroups appeared to differ with regard to the duration of pain, the 
presence of clear precipitant, the number of days in hospitalization, the number of back surgeries 
and pretreatment pain estimate. Those with elevations on multiple scales consistently had worse 
outcome than the other groups. 
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Costello, Hulsey, Schoenfeld and Rumamurthy (1987) summarized the type profile 
categorizations or cluster solutions from 10 studies on the original MMPI scales using a meta-
analytic technique. Authors used the acronym PAIN to describe the different typologies of 
previously found clusters (See Figure 1). Type P involved elevations on most of the clinical 
scales and appeared to be the most disturbed profile. The profile was associated with difficulty in 
the realms of psychological, educational, and vocational functioning. Type A was the conversion 
V profile which reported no significant pain problems. Type I appeared to be a hypochondriac 
profile associated with physical impairment, multiple surgical procedures, and multiple 
hospitalizations. Type N patients were described as relatively normal. 
 Figure 1. Costello et al., (1987) illustration of cluster solution  
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Note. L: Lie, F, Infrequency; K: Correction; 1: Hypochondriasis; 2: Depression; 3: 
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : 
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.  
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MMPI-2 Pain Subgroups 
 When the MMPI-2 was introduced, several researchers found important to investigate if 
subgroups solutions replicate when using the newer instrument. Riley, Robinson, Geisser and 
Wittmer (1993) investigated whether the MMPI-2 cluster solutions would replicate those from 
the original MMPI. Riley et al. use hierarchical agglomerative clustering procedure to examine 
the profiles of 201 low back pain patients using the ten clinical scales and traditional validity 
Scales L, F, and K. Four homogeneous clusters were identified: the largest group with all MMPI-
2 scales within normal limits (“Normal”); the second largest group with elevations on Scales 1, 
2, and 3 (“Triad” group); the third group with elevations on Scales 1 and 3 only (“Conversion V” 
group); and a small fourth group with elevations on four or more scales (Depressed-
Pathological”). See Figure 2 for an illustrative scale description of Riley et al. subgroups. In 
general, Riley et al. confirmed the existence of four pain subgroups when using the MMPI-2.  
 Figure 2. Riley et al., (1993) illustration of cluster solution 
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Note. L: Lie, F, Infrequency; K: Correction; 1: Hypochondriasis; 2: Depression; 3: 
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : 
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.  
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Subsequently, Riley, Robinson, Geisser, Wittmer, and Smith, (1995) tested the predictive 
validity of their previously found  subgroups by evaluating the outcome of 71 patients (out of the 
201 group) 6 months after surgery.  Results demonstrated significant differences in recovery 
time. Those patients classified as “Normal” obtained significant improvements. A similar 
outcome was obtained by those leveled as “Triad”. The patients leveled as “Conversion V” 
achieved poorer surgical results than did the normal and triad groups. Finally, the “Depressed-
Pathological” patients demonstrated the least improvements and diminished surgical results 
among all the patients. 
Gatchel, Mayer, and Eddington (2006) also support the utility of Riley’s MMPI-2 pain 
sub-groups (constructed based on clinical appreciation) for predicting nonsurgical treatment 
outcomes in musculoskeletal disorders. Gatchel et al. (2006) clinically classified 1,489 pain 
patients into one of four Riley et al.’s subgroups based on their elevations ( T ≥ 65) on the 
MMPI-2 clinical scales; and these groups were compared on socioeconomic, psychopathological, 
and pain measures.  Patients in the “Normal” group were twice more likely to return to work and 
less likely to have psychopathological complications than the other three groups. The 
“Pathological” group was 14 times more likely to report more pain and psychopathology than the 
normal group. The “Triad” group was 6.6 times more likely to report pain and psychopathology 
than the normal group. The “Conversion V” group did not show any significant differences from 
the Normal group or the Triad group. 
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Other cluster analytic studies have demonstrated somewhat similar results.  Block and 
Ohnmeiss (2000) also used hierarchical agglomerative clustering procedure on the MMPI-2 to 
group spine surgery candidates and determine associated outcome. All patients had spinal 
damage or findings. Similarly to Riley et al. study, Block and Ohnmeiss used the ten standard 
clinical scales and the traditional validity Scales L, F, and K. A three-cluster solution was found 
to be the best solution in examining the profiles of 222 pain patients. The described clusters 
were: a within the “Normal” limits profile (n = 114) with no scale elevations, a “Pain 
Sensitivity” profile (n = 86) that showed elevations in Scales 1,2 and 3 which resembles the 
“Triad” group, and a “Pathological” profile (n = 22) which had elevations in four or more 
MMPI-2 clinical scales resembling the Depressed-Pathological group. Interestingly, Block et al., 
did not find the typical “Conversion V” group. In terms of surgical outcome, the “Pathological” 
subgroup obtained the least improvements in functional ability and pain reduction. The within 
“Normal” profile achieved the best surgery results. The “Pain Sensitivity” profile reported more 
pain but similar improvement in functional ability when compared to the within “Normal” limits 
group.  
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Figure 3. Block and Ohnmeiss (2000) illustration of cluster solution 
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Marters, Shearer, Ogles, and Schleudener (2003) examined whether empirically-derived 
cluster profiles based on scores on the MMPI-2 predicted outcome of surgery one year for low 
back pain. Similar to Riley et al. and Block and Ohnmeiss, this study used hierarchical 
agglomerative clustering procedure on the ten standard clinical scales and the traditional validity 
scales. The authors found that the best solution was the three subgroups solution. These consisted 
of a “Pathological-Neurotic” type with high elevations on Scales 1,2, and 3 and medium 
elevations on Scales 7 and 8, a “double V” which resembles the “Conversion V” type with 
medium elevations in Scales 1 and 3, and the “Normal” type which demonstrated no elevations. 
See Figure 4 for an illustrative description of Masters et al. cluster solutions. Patients in the 
normal type were significantly more likely to report satisfaction with surgery and best surgical 
Note. L: Lie, F, Infrequency; K: Correction; 1: Hypochondriasis; 2: Depression; 3: 
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : 
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.  
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results than the other clusters. The “double V” group did not differ from the “Pathological-
Neurotic” group in any of the outcome variables.  
Figure 4. Martens et al., (2002) illustration of cluster 
solution
 
 
 
Summary 
A number of hierarchical agglomerative cluster analytic studies have helped determine 
the existence pain patient subgroups that arise from common patterns of responding on the 
original MMPI and the MMPI-2. These subgroups were a valuable addition in determining 
differences in pain perception, and patient response to treatment, as well as in decision making 
regarding whether to perform surgery.  Specifically, these studies revealed a three or four 
subgroup solutions describing a “Normal” group which is characterized by no clinical scales 
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Note. L: Lie, F, Infrequency; K: Correction; 1: Hypochondriasis; 2: Depression; 3: 
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : 
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.  
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elevations and good outcome; a “Pathological” group characterized by multiple clinical scales 
elevation and poor outcome; and “Pain Sensitivity”, “Conversion V” and/or “Triad” groups 
which are distinguished by elevations in Scales 1, 3 and/or 2 and, in general, show better 
outcome than the “Pathological” group but worse than the “Normal” group. 
 Despite the significance of previous results, the clusters were identified not taking into 
consideration differences in severity and type of the physical injuries and other factors that can 
influence symptom report such as financial compensation and malingering. Moreover, the above 
studies only included scales L, F, and K to determine the best cluster solution not considering the 
newly developed MMPI-2 validity scales. Including the new validity scales in the determination 
of subgroups could further enhance the reliability of the subgroups by increasing assurance 
regarding valid patient presentation of symptoms/disabilities. Thus, it is important to expand 
previous studies by conducting an exploratory cluster analysis on all relevant MMPI-2 scales 
over a well characterized sample in terms of the medical and legal factors that could influence 
recovery to further enhance the generalization of the results. 
 In the same way, it is also important to investigate whether the subgroup solutions 
replicate when using the newly developed MMPI-2-RF scales. Investigating whether cluster 
solutions using the MMPI-2-RF scales resemble the MMPI-2 subgroups could provide a clearer 
understanding of the strength of this instrument to determine psychological differences between 
pain subgroups and thus, increment its utility as a diagnostic tool.  
Purpose 
 The main goal of this investigation was to expand previous cluster analytic studies by 
determining the best cluster solution using MMPI-2 and MMPI-2-RF variables on a large and 
well characterized pain subgroups that were seen in medico-legal contexts.  Specifically, this 
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study examined, thoroughly described and compared: 1) the subgroups that arise when using the 
MMPI-2 standard clinical and traditional validity scales (the traditional clustering method);  2) 
the subgroups that arise when the cluster analysis is conducted also including the new validity 
scales Fb, Fp and FBS (the MMPI-2 clustering method); and 3) the subgroups that arise when 
conducting a cluster analysis on the recently developed MMPI-2-RF scales (the MMPI-2-RF 
clustering method).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
End Notes 
1Cluster analysis is a generic name for a variety of mathematical methods, numbering in 
the hundreds, which in the behavioral sciences are often used to group patients that have similar 
data. 
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CHAPTER IV 
METHODS 
Participants 
Patients were culled from the archival records of a pull of approximately 847 sequential 
cases seen for psychological pain evaluations at a large clinical psychology practice in the 
Southeastern United States from 1998 through 2008. All patients were referred by physicians, 
workers compensation companies, and attorneys. Extensive medical records were reviewed in 
the context of these evaluations to provide objective medical diagnostic test results, as well as 
physicians’ clinical diagnoses and injury descriptions. The inclusion criteria were: 1) referral for 
persisting spine pain-related complaints, 2) presence of significant external incentive primarily in 
the form of workers’ compensation claims or a personal injury law suit, and 3) completion of the 
MMPI-2.  Because all items of the MMPI-2-RF are included in the MMPI-2, it was possible to 
score MMPI-2-RF scales for all those patients that have all MMPI-2 items available. Exclusion 
criteria were: 1) age lower than 18 and greater than 59; 2) time since injury of less than 6 months 
or more than 15 years; 3) a head injury accident more severe than a concussion (as defined by the 
Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest 
Group of the American Congress of Rehabilitation Medicine, 1993). Finally, patients were 
screened according to their MMPI-2 VRIN scale, TRIN scale and Cannot Say score. Cases were 
excluded if VRIN or TRIN are greater or equal 80 or Cannot Say is equal or greater than 30 
(Butcher et al., 1989).  
 The final sample was comprised of 608 cases. The mean age for the full sample was 42.4 
years (sd = 8.8). The sample had completed an average of 11.7 years of education (sd = 2.5) and 
were 38.2 months post injury (sd = 29.3). The sample was 64.6% male and 65.6% Caucasian 
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(African-American = 28.1%; other or not indicated = 5.3%). At the time of the interview the 
patients rated their pain at 6.7 (sd = 1.9) out of a maximum of 10. Less than half (40.5 %) of 
patients had objective evidence of pathology involving the spine or spinal cord. Spine surgery 
was present in a quarter to one third of cases. Comorbid pain syndromes (e.g., fibromyalgia, 
complex regional pain syndrome) were rare (less than 10%).  
Of the full sample, patients had external incentive primarily in the form of workers 
compensation claims (82.6%) or a personal injury law suit (15.3%). Over half (55.9%) were 
represented by an attorney though less than a quarter (23.8%) were attorney-referred. The 
remainder were referred by clinicians (usually medical doctors; 28.8%) or case managers / 
adjusters (47.8%). Based on Bianchini et al. (2005) Malingered Pain-Related Disability (MPRD) 
criteria, 37.2% were classified as Not MPRD, 29.9% were Possible MPRD, 25.3% were 
Probable MPRD and 7.6% were Definite MPRD.  
Measures, Variables and Characterization 
MMPI Variables 
The Minnesota Multiphasic Personality Inventory 2nd edition (MMPI-2; Butcher et al. 
1989) is a widely used emotion and personality measure. The MMPI-2 consists of 567 items. 
Variables that were used in this study are validity scales: Cannot Say, VRIN, TRIN, L, F, Fb, Fp, 
FBS and K, (scale S was not included because it was not collected for all patients); and clinical 
scales 1 thru 0. Refer back to Table 1 for a detailed description of the MMPI-2 clinical and 
validity scales.  
T-scores were analyzed for all variables. Based on manual recommended interpretation 
cutoffs, T scores were classified as May be exaggerated or May be invalid for all for validity 
scales and High or Very high scores for all clinical scales. See Table 3 for T scores classification 
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categories by MMPI-2 scale. For details regarding cutoff, scales and indicators, the reader is 
referred to the MMPI-2 manual (Butcher et al., 1989) and Lees-Haley et al. (2003) as well as 
other standard MMPI-2 texts (e.g., Greene, 2000; Graham, 1990; Freidman, Lewak, Nichols, & 
Webb, 2001). 
 
Table 3 
T scores at or above  (≥) the interpretative cutoff based on the Lees-Haley et al. (2003) MMPI-2 
manual 
Validity Scales 
  May be exaggerated May be invalid 
F 70 90 
Fb 80 90 
Fp 70 100 
FBS 80 100 
L 65 80 
K -- 65 
Clinical Scales 
  High Very High  
All Clinical Scales (1-0) 65 75 
Note. F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom 
Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: 
Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : 
Hypomania; 0 : Social Introversion. 
 
The Minnesota Multiphasic Personality Inventory 2nd edition-Restructured Form (MMPI-2-
RF; Ben-Porath and Tallegen, 2008). The restructured form consists of 338 items. Variables that 
were used in this study are RF validity scales: L-r, K-r, F-r, Fp-r, Fs and FBS-r; and clinical 
scales: RCd thru RC9.  Refer back to Table 2 for a detailed description of the RC and RF validity 
scales. T-scores were analyzed for all variables.  
T-scores were analyzed for all variables. Based on manual recommended interpretation 
cutoffs, T scores were classified as Maybe exaggerated or May be invalid for all for validity 
scales and High or Very high for all clinical scales. See Table 4 for Diagnostic Cutoffs by 
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MMPI-2-RF scale. For details regarding cutoffs, scales and indicators, the reader is referred to 
the MMPI-2-RF manual (Ben-Porath and Tallegen, 2008). 
Table 4 
T scores at or above  (≥) the interpretative cutoff based on the Ben-Porath and Tallegen ( 2008) 
MMPI-2-RF Manual 
RF Validity Scales 
  May be exaggerated May be invalid 
F-r 90 100 
Fp-r 70 80 
Fs 80 90 
FBS-r 80 90 
L-r 70 80 
K-r 66 70 
Clinical Scales 
  High Very high  
All RC Scales (RCd-RC9) 65 80 
Note. F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs: 
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K: 
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low 
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7: 
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation. 
 
Non-MMPI variables 
Demographics variables that were examined in this study are age, gender, education 
level, race, time since injury.  
Symptom/Injury characteristics variables that were examined are pain symptoms by area of 
the body, spine findings, spinal surgery and other pain-related diagnoses. In addition, an Injury 
Severity scale was created to serve as a rough linear approximation of the degree or severity of 
spine-related medical findings. Based on a review of medical records each case was assigned a 
score of 0 to 4 as follows: no findings = 0; degenerative disc(s) or joint(s) = 1; bulging or 
protruding disc(s) = 2; herniated disc(s) = 3; and 4) neural impingement(s) = 4. Note that spine 
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severity scores were not cumulative; patients received the highest single score for which findings 
were observed.  
Medico-legal variables that were examined are status of legal representation, referral source, 
and claim type. Malingering status was also described for all patients. Malingering status was 
based on the criteria for the diagnosis of MPRD (Bianchini et al., 2005). Classification relied on 
performance on psychometric indicators and examination of available records. Patients were 
classified as MPRD based on two criteria. MPRDa  was based on performance on psychometric 
indicators not including the MMPI-2 variables. MPRDb was based on performance on 
psychometric indicators including the MMPI-2 variables. See appendix C for a description of 
psychometric indicators, cutoffs and operationalization of the malingering classification systems. 
This system results in patients being classified into one of four groups: 1) Not MPRD; 2) 
Possible MPRD (some findings but insufficient for a higher level diagnosis); 3) Probable MPRD; 
4) “Definite MPRD”. “Definite MPRD” is defined by the presence of a significantly below-
chance finding. “Probable MPRD” is defined in terms of two or more psychometric findings 
consistent with malingering or two or more qualitative inconsistencies along with one or more 
psychometric findings. Cases that had psychometric findings or two or more qualitative 
inconsistencies but who did not meet these criteria were considered “Possible MPRD”. Cases 
who do not meet any of the above criteria were classified as “Not MPRD.”  Finally, the Probable 
and Definite MPRD patients were combined as “All MPRD” group as both are considered 
malingering in the MPRD criteria.  
Pain Perception and Predictors of Outcome variables 
Pain Perception was examined by patients’ report of their level of pain on a scale ranging 
from 0 (No Pain) to 10 (Worst Pain Imaginable) at the time of the interview (current), when they 
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had the least amount of pain (best) and when they had the most amount of pain (worst) after the 
injury. 
 The Pain Catastrophizing Scale (PCS; Sullivan et al., 1995) was be used to measure the 
construct of pain catastrophization which includes a hypervigilance, threat magnification, and 
feeling of helplessness related to pain. PCS consists of 13 statements related to pain that are each 
rated (0-4) as to the degree felt during painful experiences. PCS T scores were used in this study. 
It is important note that the PCS was introduced to the psychological practice in 2005 and only 
140 patients included in this study have scores. 
Perceived Disability was measure using  the Pain Disability Index (PDI; Pollard, 1984) 
assesses pain disability in seven areas (occupational, home/family, recreational, social, sexual, 
activities of daily living, life support), all rated on 11-point Likert-type scales (0, no disability; 
10, complete disability ; see appendix B). Raw scores were used for this study because T scores 
were not available. The PDI has had widespread use since its introduction because it is brief and 
has strong psychometric properties, including evidence for validity (Jerome & Gross, 1991; Tait, 
Chibnall, & Krause, 1990; Tait, Pollard, Margolis, Duckro, & Krause, 1987), reliability 
(Gronblad et al., 1993), and sensitivity to change (Strong, Ashton, & Large, 1994). The PDI was 
introduced to the psychological practice in 2004 and only 241 patients included in this study 
have PDI scores.  
Analysis Strategy 
Using three different methods, exploratory two-step cluster analyses1 were conducted to 
group the participants. The two-step cluster analysis was selected as the clustering method 
because is often the method preferred for large data sets as hierarchical clustering do not scale 
efficiently when number of subjects is very large e.g. n > 200 (Milligan& Hirtle, 2003). 
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Method 1. (the traditional clustering method) used the MMPI-2 standard clinical scales 
and the traditional validity scales L, F and K. to test whether the previously found pain subgroups 
are also found in the present medico-legal sample.  
Method 2. (the MMPI-2 clustering method) used all the MMPI-2 standard clinical scales 
and all the validity scales including L, F, K, Fb, Fp and FBS to test whether the inclusion of the 
over reporting validity scales in the cluster analysis impact the number and the characteristics of 
pain subgroups in the current medico-legal sample (the MMPI-2 clustering method).  
 Method 3. (the MMPI-2-RF clustering method) used the MMPI-2-RF RCd- RC9 and RF 
validity scales to test whether a cluster analysis using the newly developed MMPI-2-RF scales 
influence the previously found MMPI-2 cluster number and characteristics.  
For each method, it was determined the best cluster solution (number of clusters) from 
the autoclustering technique of the Statistical Package for the Social Sciences- 14th edition (SPSS 
14). Then, Multivariate Analysis of Variance (MANOVA), Analysis of Variance (ANOVA) or 
Chi squared analysis were conducted, where appropriate, to determined differences between the 
resulted subgroups in several important variables:  MMPI-2, MMPI-2-RF, demographics, injury 
severity, legal status, malingering status, pain perception and predictors of poor outcome. 
 
 
 
 
 
 
End Notes 
1Two-step cluster analysis is often preferred Clustering method for large datasets, since 
hierarchical and k-means clustering do not scale efficiently when n is very large 
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CHAPTER V 
RESULTS 
Preliminary Analyses 
 Before running the cluster analyses, assumptions of normality and independence of 
variables were evaluated. The distributions presented in Table 5 indicated that all MMPI-2 and 
MMPI-2-RF variables were relatively normally distributed (Skewness and Kurtosis < + or -2.0; 
Shapiro & Wilk, 1965). However, FBS demonstrated an elevated Kurtosis statistic of 2.66. 
Results also indicated that most MMPI-2 variables meet the assumption of independence of 
variables (r < .80; Tabachnick & Fidell, 2001). However, there was high multicollinearity 
between scales Fb and 8 (r = .81) and between scales 7 and 8 (r = .85).  
All the MMPI-2-RF scales showed low to medium correlations between each other, 
meeting the assumption of independence of variables (r < .80; Tabachnick & Fidell, 2001). 
Therefore, the assumptions of normality and independence of variance were not fully met for all 
the MMPI-2 variables; these assumptions were met for the MMPI-2-RF variables. Despite the 
MMPI-2 results, all the proposed cluster analyses were performed because the two-step cluster 
analysis is fairly robust even when the normality and independence of variables assumptions are 
violated (Milligan& Hirtle, 2003). 
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MMPI-2-RF Scales 
  
L-r 0.31 0.11 -1.12 0.23 
F-r 1.29 0.11 1.69 0.23 
Fp-r 0.56 0.11 -0.54 0.23 
Fs 0.02 0.11 -0.68 0.23 
FBS-r 0.31 0.11 -0.20 0.23 
K-r 0.29 0.11 -0.65 0.23 
RCd -0.35 0.11 -0.74 0.23 
RC1 0.09 0.11 -0.84 0.23 
RC2 0.13 0.11 -0.73 
 
0.23 
 
Table 5 
 Normality statistics for the MMPI-2 and MMPI-2-RF variables 
 
 Skewness Kurtosis 
MMPI-2 Scales Statistic Standard Error Statistic Standard Error 
L 0.54 0.10 0.39 0.20 
F 0.98 0.10 0.55 0.20 
Fb 0.33 0.10 -0.73 0.20 
Fp 0.66 0.10 -0.75 0.20 
FBS 1.48 0.10 2.66 0.20 
K -0.04 0.10 -0.46 0.20 
1 -0.10 0.10 -0.21 0.20 
2 -0.38 0.10 -0.41 0.20 
3 -0.05 0.10 -0.25 0.20 
4 0.28 0.10 -0.41 0.20 
5 0.21 0.10 0.04 0.20 
6 0.51 0.10 -0.17 0.20 
7 -0.02 0.10 -0.47 0.20 
8 0.34 0.10 -0.43 0.20 
9 0.71 0.10 0.12 0.20 
0 0.19 0.10 -0.70 0.20 
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Table 5 Cont. 
 
RC3 
 
 
0.34 
 
 
0.11 
 
 
-0.88 
 
 
0.23 
RC4 0.59 0.11 -0.25 0.23 
RC6 0.88 0.11 0.25 0.23 
RC7 0.27 0.11 -0.79 0.23 
RC8 0.58 0.11 -0.24 0.23 
RC9 0.72 0.11 0.99 0.23 
Note. F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom 
Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: 
Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : 
Hypomania; 0 : Social Introversion. . F-r: Infrequency restructured; Fp-r: Infrequency psychopathology 
restructured; Fs: Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie 
restructured; K: Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic 
Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of 
Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic 
Activation. 
 
Method 1: Traditional Clustering Method 
Defining the Number of Clusters  
In Method 1 an exploratory two-step cluster analysis was conducted using the MMPI-2 
traditional validity scales L, F and K and the ten clinical scales. As mentioned above, the 
autoclustering selection from SPSS 14 was used to select the best cluster solution. As a rule of 
thumb, the SPSS autoclustering will select as the best solution the one with the lowest 
information criterion measure (the Schwarz Bayesian Information Criterion; BIC) and the 
highest ratio of distance measures (RDM; “SPSS 14”, 2005).  
 Because autoclustering solution is affected by order of the data (Milligan& Hirtle, 2003), 
first, autoclustering was conducted on the full data set ordering the data ascendingly by patient’s 
ID number. Results showed that the optimal number of clusters was the two cluster solution. In 
support of the two-cluster solution, there was dramatic jump in variance explained from the one 
(BIC = 5412.4) to two (BIC = 4422.7; RDM = 2.8) cluster solution with only modest increases 
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when three (BIC = 4170.0; RDM = 2.1) and four clusters (BIC =4098.7, RDM = 1.4) solutions 
were isolated.  
Then, full data set was sorted descendingly by patient’s ID number. This time it was 
determined that the optimal number of clusters was the three-cluster solution. In support of the 
three-cluster solution, there was dramatic jump in variance explained from one (BIC = 5007) to 
two (BIC = 4525.6; RDM = 2.2) cluster solution and a similar jump from two to three (BIC = 
4202.7, RDM = 2.0) cluster solution with only a modest decrease when four (BIC = 4127.2; 
RDM = 1.7) and five clusters (BIC =4135.5; RDM = 1.1) solutions were isolated.  
Selection of Best Cluster Solution 
To select the “best” cluster solution, 50 cluster analyses were all run after randomly 
sorting the data set using 70% of the total sample. Out of the 50 runs, autoclustering determined 
that the two-cluster solution was more adequate 33 times (66 %) while the three-cluster solution 
was the most adequate 10 times (20%) and a four-cluster solution was most adequate 7 times 
(14%). Results using Binomial Tests demonstrated significant differences between observed 
proportion and the expected proportion between the appearance of the two and three-cluster 
solution and the two and four-cluster solutions (p< .001). Thus, the two-cluster solution was 
considered the most adequate number of groups for Method 1. The two-cluster solution was 
composed by a group with 342 participants and a group with 267 participants and these were 
further described in a number of MMPI, non-MMPI, pain perception and predictor of outcome 
variables. 
Characterization of Pain Clusters based on all MMPI Variables 
MMPI-2 Variables. First, the two subgroups were described and compared on all available 
MMPI-2 variables, this included the over reporting scales Fb, Fp and FBS even when these were 
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not used to determine the groups. Multivariate Analysis of Variance (MANOVA) demonstrated 
overall differences in MMPI-2 variables between the two groups [Wilk’s Lambda; F (16, 564) = 
10784.0, p<.001, Eta2=.99]. Subsequent Analysis of Variance (ANOVA) and Tukey’s b post hoc 
analyses demonstrated significant differences between the two groups in all the MMPI-2 
variables. Table 6 presents means and standard deviations for all MMPI-2 scales by each 
subgroup.  Figure 5 illustrates the profiles of the two subgroups based on the variables used to 
create the clusters. As can be seen in Figure 5, one subgroup had no elevated validity scales and 
three scales (scales 1, 2 and 3) with very high mean scores (this group was called Method 1-
Triad). The second group, on the other hand, had two mean scores (scales F and FBS) in the may 
be exaggerated range, one score (scale Fb), in the may be invalid range, two scales (scales 4 and 
0) with high mean scores, and six scales (scales 1, 2, 3, 6, 7 and 8) with very high mean scores 
(this subgroup was called Method 1-Pathological).  
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Table 6 
Method 1 MMPI-2 mean, standard deviations, and statistical differences by subgroup 
  
M1- 
Triad 
M1-  
Pathological      
  M(sd) M(sd)  F p< Eta2 
L 63.0(11.7) 57.4 (10.2)  35.6 .001 0.06 
F 55.3(8.9) 82.0 (16.9)  604.2 .001 0.51 
Fb 55.6(8.9) 91.9 (19.2)  744.5 .001 0.56 
Fp 51.4(9.7) 64.0(15.9)  140.4 .001 0.20 
FBS 75.9(13.6) 90.7(12.0)  185.6 .001 0.24 
K 53.9(10.5) 41.4(7.9)  248.3 .001 0.30 
1  79.0(10.4) 86.2(8.5)  77.8 .001 0.12 
2 75.6(12.6) 90.0(9.5)  234.5 .001 0.29 
3 81.4(15.3) 87.7(12.9)  27.6 .001 0.05 
4 58.6(10.1) 70.6(11.8)  174.8 .001 0.23 
5 49.3(10.1) 51.6(8.1)  8.7 .003 0.02 
6 56.0(11.9) 82.2(15.3)  539.3 .001 0.48 
7 63.9(11.3) 85.7(10.1)  575.5 .001 0.49 
8 64.5(9.9) 91.0(12.2)  831.7 .001 0.59 
9 50.2(9.2) 57.2(11.5)  64.8 .001 0.10 
0 52.8(8.6) 69.2(9.4)   479.9 .001 0.46 
Note. M1-Triad: M1 subgroup with a Triad profile; Method 1-Pathological : Method 1subgroup with a 
Pathological profile; F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: 
Symptom Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: 
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: 
Schizophrenia; 9 : Hypomania; 0 : Social Introversion. 
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Figure 5.  Method 1 illustration of the profiles of the two subgroups described by all the 
MMPI-2 scales 
 
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile; F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: 
Symptom Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: 
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: 
Schizophrenia; 9 : Hypomania; 0 : Social Introversion. 
 
The number of patients that scored at or above the selected scores was also different 
between the two groups. As can be seen in Table 7, the Method 1-Pathological subgroup had 
significantly more patients scoring at the may be exaggerated and maybe invalid ranges than 
Method 1-Triad subgroup; exceptions were scales L and K where the Method 1-Triad had more 
patients than the Method 1-Pathological at those ranges. Method 1-Triad and Method 1-
Pathological subgroups had similar number of patients with high mean scores on scales 1, 2, and 
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3. However, the Method 1-Pathological had a higher percentage of patients than Method 1-Triad 
with very high mean scores on the same scales. The most noticeable differences in the clinical 
scales were in scales 4, 6, 7, 8 and 0 where the Method 1-Pathological had at least four times 
more patients than the Method 1-Triad with very high mean scores. 
Table 7     
Method 1 percentage of cases that fall above the interpretative cutoff per MMPI-2 variable 
   Maybe exaggerated   Maybe invalid 
Scale  M1-Triad M1-Pathological  M1-Triad M1-Pathological
              
F  7 77  0 28 
Fb  4 67  2 55 
Fp  5 35  0 4 
FBS  41 85  6 23 
L  47 28  8 2 
K   15 2  2 0 
  High scores   Very high scores 
    M1-Triad M1-Pathological  M1-Triad M1-Pathological
1  94 97  68 90 
2  78 100  54 96 
3  85 96  67 83 
4  28 68  6 37 
5  8 6  1 0 
6  23 86  7 67 
7  47 99  18 87 
8  53 99  16 93 
9  10 27  2 9 
0   10 69   1 25 
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile; F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: 
Symptom Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: 
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: 
Schizophrenia; 9 : Hypomania; 0 : Social Introversion. 
 
MMPI-2-RF Variables. The two subgroups were also characterized using all MMPI-2-RF 
scales. This was done to determine similarities and differences between the two MMPI versions 
when testing pain patient subgroups. MANOVA demonstrated overall differences in MMPI-2-
RF mean scores between the two groups [Wilk’s Lambda; F (15, 434) =18428.8, p<.001, 
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Eta2=1.00]. Subsequent ANOVA and Tukey’s b post hoc analyses demonstrated that there were 
significant differences between the groups in all the MMPI-2-RF variables. Table 8 presents 
scales mean and standard deviations for each group.  Figure 6 illustrates the two subgroups based 
on MMPI-2-RF variables. Table 8 and Figure 6 show that the M1-Triad has no elevated validity 
scales and only one scale with very high mean score (RC1). The M1-Pathological, on the other 
hand, had two mean scores in the may be exaggerated range (scales Fs and FBS-r), one score in 
the may be invalid range (scale F-r), four high mean scores (RCd, RC2, RC6, RC7, RC8), and 
one very high mean score (scale RC1). 
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Table 8 
 Method 1 MMPI-2-RF mean, standard deviations, and statistical differences by subgroup. 
 
 
 
M1-Triad 
M(sd) 
M1-Pathological 
M(sd) F p< Eta2 
L-r 62.9 (12.2) 60.1 (11.6) 6.1 .014 0.01 
F-r 66.4(12.0) 102.5 (15.8) 458.5 .001 0.63 
Fp-r 51.0(8.9) 70.7(17.5) 239.5 .001 0.35 
Fs 60.3(14.6) 83.9(19.1) 219.5 .001 0.33 
FBS-r 71.8(13.4) 88.1(12.1) 180.0 .001 0.29 
K-r 49.6(9.9) 37.9(7.5) 192.5 .001 0.30 
RCd 56.6(9.8) 74.8(7.1) 488.1 .001 0.52 
RC1 71.6(9.8) 85.3(9.5) 223.4 .001 0.33 
RC2 61.9(11.2) 75.9(12.1) 158.1 .001 0.26 
RC3 50.0(12.3) 54.5(12.1) 67.5 .001 0.13 
RC4 46.1(50.6) 56.2(11.8) 61.4 .001 0.12 
RC6 53.1(9.9) 73.3(116.6) 279.6 .001 0.38 
RC7 48.4(9.2) 68.6(10.8) 461.1 .001 0.51 
RC8 50.8(9.2) 69.5(13.9) 292.8 .001 0.40 
RC9 42.7(9.2) 49.6(9.5) 57.2 .001 0.11 
Note M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile; . F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs: 
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K: 
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low 
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7: 
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation. 
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Figure 6. Method 1 illustration of the profiles of the two subgroups described by all the 
MMPI-2-RF scales. 
 
 
 
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological: Method 1subgroup with a 
Pathological profile; . F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs: 
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K: 
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low 
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7: 
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation. 
 
 In addition, as can be seen in Table 9, the Method 1-Pathological had at least ten times 
more patients scoring at the may be exaggerated and maybe invalid ranges than the Method 1-
Triad on the over-reporting validity scales. Method 1-Triad and Method 1-Pathological had 
similar number of patients with high mean scores on scale RC1. However, the Method 1-
Pathological had noticeably more patients than the Method 1-Triad with very high mean scores 
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on the same scale. The most visible differences between the groups were in scales RCd, RC6, 
RC7, and RC8 where Method 1-Triad had about 10% of patients scoring at the high scores range 
while the Method 1-Pathological had more than 60% of patients scoring at the same range.  
Table 9       
Method 1 percentage of Cases that fall above the selected cutoff per MMPI-RF variable 
 May be exaggerated    May be invalid  
Scale 
M1 
-Triad 
M1- 
Pathological  
M1- 
Triad 
M1- 
Pathological  
F-r 3 70  0 61  
Fp-r 1 26  0 13  
Fs 13 58  6 44  
FBS-r 32 81  8 42  
L-r 30 23  12 6  
K-r 7 0   0 0  
 High scores  Very high scores  
  M1- Triad 
M1- 
Pathological  
M1- 
Triad 
M1- 
Pathological  
RCd 24 91  0 31  
RC1 79 99  20 72  
RC2 45 83  9 43  
RC3 14 42  2 3  
RC4 8 24  0 2  
RC6 15 70  1 34  
RC7 6 65  0 20  
RC8 7 62  0 22  
RC9 3 7   0 1  
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile; F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs: 
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K: 
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low 
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7: 
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation. 
 
Non-MMPI Characteristics of Pain Clusters 
Demographics. Differences between the two resulted groups in demographic report were 
tested using ANOVA or Chi squared analysis where appropriate. Table 10 presents demographic 
data by group. The Method 1-Triad patients were significantly shorter post- injury and had a 
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higher education than those in the Method 1-Pathological subgroup. Method 1-Pathological 
subgroup also had less number of male participants and Caucasians. Indeed, odd ratios analysis 
indicated that the Method 1-Pathological subgroup was 1.4 times (95% C.I. = 1.3-1.5) less likely 
to be male and 2.0 times (95% C.I. = 1.5-1.3) less likely to be Caucasian than the Method 1-
Triad subgroup. 
Table 10 
 Method 1 demographic characteristics by subgroup 
 
  
M1- 
Triad 
M1- 
Pathological   F p≤ Eta2 
  M(sd) M(sd)         
Age 42.6 (8.9) 42.5(8.5)  0.2 NS 0.00 
Education 12.0(2.5) 11.5(2.4)  6.7 .012 0.11 
Time since Injury  35.7(27.7) 41.8(30.8)   3.2 .013 0.00 
  (%) (%)   X2 p≤  
Gender (male) 68.9 60.2  4.7 .031  
Race (white)  72.6 57.0   20.4 .001  
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile 
 
Injury Severity. Univariate ANOVA demonstrated that there are not differences in the Injury 
Severity scale between Method 1-Triad (M = .79; sd = 1.2) and Method 1-Pathological (M = .81; 
sd = 1.1) [F (1, 583) = 0.06, p > .05, Eta2=0.01]. Table 11 presents the injury and symptom 
characteristics of the sample as a function of group membership. Differences between the two 
groups in injury/symptom characteristics were also tested using Chi squared analysis. As can be 
seen, groups did not differ in injury type, location, or etiology.  
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Table 11 
Method 1 percentage of patients with specific Injury/Symptom characteristics by pain group 
 
  M1-Triad M1-Pathological X2 p< 
Primary back/spine injury 91.6 88.9 1.8 NS 
Head injury in accident 8.3 8.0 3.9 NS 
Other Pain symptoms / area of body     
Head 23.9 30.2 4.3 NS 
Chest / abdomen 5.0 9.3 3.7 NS 
Upper extremity 42.2 42.0 1.3 NS 
Lower extremity 69.4 66.0 0.5 NS 
Spine Findings     
any spine findings 40.0 36.4 0.5 NS 
degenerative disc/spine  20.0 21.6 0.3 NS 
herniated nucleus pulposus 5.6 5.6 0.6 NS 
disc bulge/protrusion 26.7 22.8 0.8 NS 
neural impingement 2.8 3.1 1.7 NS 
Spinal Surgery     
discectomy / fusion 26.7 30.9 3.2 NS 
decompression/laminectomy 11.7 17.9 2.8 NS 
Other pain diagnoses     
Complex regional pain syndrome 2.8 3.7 1.0 NS 
Fibromyalgia 2.8 3.1 0.9 NS 
Myofascial pain syndrome 1.7 6.2 4.7 NS 
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile 
  
 
Legal Status. Differences between the two subgroups in legal characteristics were tested 
using Chi squared analysis. Table 12 presents the legal status of the sample as a function of 
group membership. Groups did not differ in the status of legal representation, referral source or 
type of legal claim.  
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Table 12     
Method 1 medico-legal characteristics of the chronic pain sample as a function of group 
membership. 
     
M1-Triad M1-Pathological   
 % % X2 p= 
Status of legal representation     
No Attorney 29.8 27.1 
0.55 NS Represented by attorney 57.4 55.7 
Attorney status unknown 15.5 14.5 
Referral source     
doctor 28.0 27.1 
0.66 NS case manager / adjuster 49.8 47.9 attorney 4.4 3.6 
district attorney 18.3 19.9 
Claim type   
3.60 NS 
workers compensation 87.3 81.9 
personal injury 11.6 17.2 
disability 0.8 0.6 
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile 
 
Malingering Diagnosis. Differences between the two subgroups in MPRDa and MPRDb 
diagnosis were also tested using Chi squared analysis. Table 13 presents the malingering 
diagnosis of the sample as a function of group membership. The two subgroups differed 
significantly in MPRD status: MPRDa [Χ2 (4,583) = 104.5, p< .001].Odd ratios analysis 
indicated that the Method 1-Pathological was 10.5 times (95% C.I. = 10.6-10.5) more likely to 
be MPRD than Method 1-Triad subgroup when not using the MMPI variables as malingering 
indicators. When the MMPI variables were included as indicators the odds ratio increased to 27.8 
(95% CI = 27.8- 27.5). 
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Table 13 
Method 1Malingering status by pain group 
 
Method 1 MPRDa status by subgroup         
  
M1- 
Triad 
M1- 
Pathological    
  % % X2 p< 
Not MPRD 43.4 14.2 
104.5 .001Possible MPRD 26.5 33.9 Probable MPRD 15.4 39.8 
Define MPRD 4.8 12.0 
All MPRD 20.2 51.8     
     
Method 1 MPRDb status by subgroup     
  M1-Triad M1-Pathological    
  % % X2 p< 
Not MPRD 42.2 3.6 
138.9 .001Possible MPRD 32.8 31.1 Probable MPRD 20.2 53.4 
Define MPRD 4.8 12.0 
All MPRD 25.0 65.4     
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile MPRDa: Malingered Pain Related Disability not including the MMPI-2 variables; 
MMPIb: Malingered Pain Related Disability including the MMPI-2 variables
 
Pain Report and Predictors of Outcome. Finally, to determine differences in pain report and 
predictors of outcome, pain reports, levels catastrophization and functional capacity were 
compared among the two subgroups. Differences between the two groups in pain report, PCS 
and PDI scores were tested using ANOVA. Pain reports were available for all patients. PCS 
scores were available for 72 participants from the Method 1-Triad subgroup and for 68 
participants from the Method 1-Pathological subgroup. PDI data was available for 118 
participants from the M1-Triad subgroup and 95 participants from the M1-Pathological 
subgroup. Table 14 presents data for these variables by group. Results showed that the Method 1-
Pathological reported significantly higher levels of “best” pain, catastrophization and perceived 
disability than those in the Method 1-Triad.  
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Table 14 
Method 1 current, best, worst pain report, PCS and PDI scores as a function of pain group 
       
  M1-Triad M1-Pathological      
  M(sd)  M(sd)     F p<  Eta2 
Current Pain 6.4(2.0) 6.7(1.8)  2.2 NS 0.10 
Best Pain 4.6(2.1) 5.1(2.2)  4.7 .032 0.10 
Worst Pain 9.2(1.5) 9.2(1.3)  0.1 NS 0.00 
PCS 69.3(14.5) 80.9(13.3)  24.2 .001 0.15 
PDI 48.6(13.1) 55.5(10.0)   17.4 .001 0.08 
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a 
Pathological profile. 
 
Method 1 Summary and Conclusions 
After conducting several exploratory two step cluster analyses using the MMPI-2 
traditional validity scales L, F and K and the 10 clinical scales it was determined  that the best 
solution was the two-cluster solution because it was picked by SPSS autoclustering significantly 
more frequently as the best solution than the other solutions. The two-cluster solution was 
characterized by two homogeneous groups that differed drastically in the number and type of 
MMPI-2 scales elevated as well as the number of patients with elevations.  The first subgroup 
elevated only on scales 1, 2 and 3; thus it was called Method 1-Triad. The second subgroup had 
elevations on scales F, 1,2,3,4,6,7,8 and 0 and it was called Method 1-Pathological. Note that the 
scores on scales 1, 2 and 3 were significantly higher in the Method 1-Pathological than the 
Method 1-Triad subgroup. 
 Differences between the subgroups were seen also in scales Fb, Fp and FBS although 
these scales were not used as variables to create the groups.  This suggests that the new over-
reporting scales not only have an important relationship with the other scales (e.g., scale F) but 
also present important information regarding the validity of the symptom presentation by patients 
in the Method 1-Pathological subgroup. Moreover, the two determined pain subgroups differed 
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on the MMPI-2-RF scales. Like the MMPI-2, the Method 1-Pathological reported higher mean 
score and a larger number MMPI-2-RF scale scores than the Method 1-Triad.  However, some 
differences between the versions were observed. The Method 1-Triad had only one very high 
mean score (RC1) on the MMPI-2-RF as opposed to three scales with very high scores (scales 1, 
2, and 3) on the MMPI-2. This shows that there are differences in describing the same Method 1-
Triad profile when using the MMPI-2 and the MMPI-2-RF. Furthermore, while the Method 1-
Pathological demonstrated similar profiles between the MMPI test versions, on the MMPI-2-RF 
two mean clinical scales were not elevated (RC3 and RC4) that were elevated on the MMPI-2. 
Thus, the changes done for RC3 and RC4 (from scales 3 and 4) make the scales less sensitive to 
report of pain symptoms related to the Method 1-Pathological profile.  
When the groups were compared on demographic, injury/symptom characteristics, legal 
status and malingering diagnosis, differences were found only on few variables. The Method 1-
Pathological was less educated, had more time post- injury, had less Caucasians, less males, and 
more malingerers than the Method 1-Triad. In fact, Method 1-Pathological patients were 10 to 
28 times more likely to be diagnosed as malingerers than the Method 1-Triad patients. These 
results reveal that group membership was not conditioned to injury/ symptom severity or legal 
status. Instead, group membership was related to some demographic characteristics and 
malingering diagnosis. Finally, best pain report levels, level of catastrophization and perceived 
disabilities were significantly higher for the Method 1-Pathological than the Method 1-Triad. 
These results support the idea that those with Method 1-Pathological profiles are more likely to 
have poorer outcome than Method 1-Triad profiles.  
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Method 2: MMPI-2 Clustering Method 
Defining the Number of Clusters  
In Method 2, an exploratory two step cluster analysis was conducted using the MMPI-2 
validity scales F, Fb, Fp, FBS, L and K and the ten clinical scales.  As done in Method 1, SPSS 
autoclustering was used to determine the best cluster solution. Again, the full data set was first 
ordered ascendingly by patient’s ID number when the autoclustering was performed. It was 
determined that the optimal number of clusters was the two-cluster solution. In support of the 
two-cluster solution, there was a dramatic jump in variance explained from the one (BIC = 
6639.2) to two (BIC = 5358.9; RDM = 2.4) cluster solution with only modest increases when 
three (BIC = 5108.5; RDM = 1.9) and four-cluster (BIC =4977.9; RDM = 1.3) solutions were 
isolated. 
Then, the data was sorted ascendingly by ID and autoclustering determined that the three-
cluster solution was the optimal solution. In support of the three-cluster solution, there was a 
dramatic jump in variance explained from one (BIC = 6639.17) to two (BIC = 5426.8; RDM = 
1.9) and a greater dramatic jump from two to three (BIC = 4998.3; RDM = 2.4) cluster solution 
with only modest increases when four (BIC = 4970.2; RDM = 2.1) and five cluster (BIC =5001.5; 
RDM = 1.0) solutions were isolated.   
Selection of Best Cluster Solution. To select the “best” cluster solution, 50 cluster analyses 
were run after randomly resorting the data set using 70% of the total sample. Out of the 50 runs, 
autoclustering determined that the two-cluster solution was most adequate 23 times (46 %), the 
three-cluster solution was also the most adequate  23 times (46%) and a four-cluster solution was 
most adequate only 4 times (8%). Results using Binomial Tests showed that there were no 
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significant differences between observed proportion and the expected proportion between the 
appearance of the two-cluster and three-cluster solutions (p > .05). The two-cluster and the three-
cluster solutions appeared significantly more times than the four-cluster solution (p< .001). This 
suggests that the two-cluster solution and the three-cluster solution can be considered equally 
adequate when using the all the validity MMPI-2 as a clustering method.  
The two subgroups found in the two-cluster solution for Method 2 were: a group (Method  
2- solution 2-A) with 323 participants and a group (Method 2- solution 2-B) with 258 
participants. The three subgroups identified in the three-cluster solution were: a group (Method 
2-solution 3-A) with 180 participants, a group (Method 2-solution 3-B) with 251 participants and 
a group (Method 2-solution 3-C) with 150 participants. Using crosstab analysis it was determined 
that all subjects classified in subgroup Method 2-solution 3-A were originally in subgroup 
Method 2- solution 2-A. Similarly, all subjects classified as Method 2-solution 3-C were 
originally in subgroup Method 2-solution 2-B. Subgroup Method 2-solution 3-B was composed 
by 49% of subjects that were in subgroup Method 2-solution 2-A and 51% of subjects that were 
in Method 2-solution 2-B.  
Figure 7 presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster 
and the three-cluster solutions. As can be seen, when compared to the two-cluster solution, the 
three-cluster solution presents Triad and Pathological profiles that differ substantially in the 
elevation of scores. Moreover, the three-cluster profile demonstrated the existence of a Moderate 
profile that is comprised of those patients that scored in the upper end of the two-cluster Triad 
profile and those that scored in the lower end of the two-cluster Pathological profile. 
Therefore, since the three-cluster solution provides 1) the most number of groups, 2)  
information about a Moderate subgroup, and 3) creates larger separation between the Triad and 
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Pathological profiles,  the three-cluster solution was determined as the most comprehensive fit 
for Method 2. As a result, the three subgroups that resulted from this solution were further 
described using a number of MMPI, non-MMPI, pain perception and predictor of outcome 
variables. 
Figure 7. presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster 
and the three-cluster solutions 
 
Note. F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom 
Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: 
Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : 
Hypomania; 0 : Social Introversion. 
 
Characterization of Pain Clusters based on all MMPI Variables 
MMPI-2 Variables. As expected, MANOVA demonstrated overall differences in MMPI-2 
mean scores between the three groups [Wilk’s Lambda; F(16, 563) = 13532.5, p<.001, 
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Eta2=.99]. Subsequent ANOVA and Tukey’s b post hoc analyses demonstrated that there were 
significant differences between the three subgroups on all the MMPI-2 variables. Table 15 
presents scale means and standard deviations for each group. Figure 8 illustrates the subgroup 
profiles. 
As can be seen in Table 15 and Figure 8, the first subgroup (called above Method 2-
Solution 3-A) had no elevated validity scales, two scales (scales 2 and 3) with high mean scores 
and one scale (scale 1) with a very high mean score; thus this group was referred Method 2-
Triad. The second subgroup (called above Method 2-Solution 3-B) had one mean score (FBS) in 
the may be exaggerated range, one scale (scale 6) with a high mean score, and five scales (scales 
1, 2, 3, 7 and 8) with high mean scores; this group was referred as Method 2-Moderate.  Finally, 
the last subgroup (called above Method 2-Solution 3-C) had three scores (scale F, Fb and FBS) in 
the may be invalid range, two high mean scores (scales 4 and 0), and six scales (scales 1, 2, 3, 6, 
7 and 8) with high mean scores; this group was referred as Method 2-Pathological). 
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Table 15 
Method 2 MMPI-2 scales means and standard deviations by group 
  
M2- 
Triad 
M2- 
Moderate 
M2- 
Pathological      
  M(sd) M(sd) M(sd)  F p≤ Eta2 
L 63.6(12.4)a 60.4(10.7)b 57.3 (10.5)c  12.8 .001 0.04 
F 51.9(8.0)a 63.7(10.8)b 89.7(15.9)c  445.8 .001 0.61 
Fb 50.7(8.0)a 63.7(10.8)b 89.7(15.9)c  632.8 .001 0.69 
Fp 51.2(10.8)a 53.5(9.4)a 69.0(17.0)b  103.5 .001 0.26 
FBS 68.0(9.7)a 85.5(11.5)b 93.8(11.4)c  247.2 .001 0.46 
K 55.7(10.6)a 48.7(10.3)b 39.6(6.9)c  114.7 .001 0.28 
1  74.6(8.3)a 84.1(9.4)b 87.9(8.2)c  105.5 .001 0.27 
2 67.6(9.2)a 86.0(8.8)b 91.7(9.2)c  339.9 .001 0.54 
3 73.7(11.4)a 88.9(14.5)b 88.5(11.6)b  85.6 .001 0.23 
4 55.0(8.7)a 64.4(11.0)b 73.1(11.0)c  126.2 .001 0.30 
5 49.2(11.0)a 50.0(8.7)a 52.2(7.9)b  4.6 .011 0.02 
6 50.1(9.5)a 66.3(11.4)b 89.3(13.7)c  475.3 .001 0.63 
7 56.7(8.5)a 75.7(8.6)b 89.2(9.9)c  557.7 .001 0.66 
8 58.8(8.3)a 75.0(8.5)b 97.7(75.8)c  796.4 .001 0.73 
9 50.1(9.2)a 52.0(10.5)a 58.8(11.2)b  32.0 .001 0.10 
0 49.9(8.0)a 59.7(9.6)b 71.8(8.4)c   251.5 .001 0.47 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; F: Infrequency; Fb: 
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K: 
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5: 
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social 
Introversion 
65 
 
 
 
 
Figure 8 illustrates the subgroup profiles for the Method 2 most comprehensive solution 
by MMPI-2 scales 
 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; F: Infrequency; Fb: 
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K: 
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5: 
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social 
Introversion 
 
The number of patients that scored at or above the interpretative cutoffs was also 
different between the three groups. As can be seen in Table 16, the Method 2-Pathological had 
considerably more patients scoring at the may be exaggerated and maybe invalid ranges than the 
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Method 2-Triad and the Method 2-Moderate. The Method 2-Moderate had consistently more 
patients with elevated scores than the Method 2-Triad in all over-reporting scales, especially on 
FBS. However, on scales L and K, the Method 2-Triad had more patients with elevated scores 
than the other subgroups. All subgroups had similar number of patients with high mean scores on 
scales 1, 2, and 3. However, the Method 2-Moderate and the Method 2-Pathological had more 
patients than the Method 2-Triad with very high mean scores on the same scales. The most 
noticeable differences in the clinical scales were in scales 6, 7 and 8 where the Method 2-Triad 
had less than 5%, the Method 2-Moderate had about 50%, and the Method 2-Pathological had 
more than 85% of patients with very high mean scores.  
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Table 16 
Method 2 percentage of cases that fall above the selected cutoff per subgroup and MMPI-2 variable 
 
 Maybe exaggerated  Maybe invalid  
 
   M2-
Triad 
M2-
Moderate 
M2-
Pathological  
    M2-
Triad 
M2-
Moderate 
M2-
Pathological  
Scale               
F 3 28 92  0 2 43  
Fb 1 17 91  0 8 81  
Fp 7 8 47  0 0 5  
FBS 13 73 93  0 13 33  
L 48 38 29  10 4 3  
K - - -  18 7 0  
 High Scores  Very High Scores  
    M2-Triad 
M2-
Moderate 
M2-
Pathological  
    M2-
Triad 
M2-
Moderate 
M2-
Pathological  
1 91 99 99  54 86 93  
2 60 99 99  25 91 96  
3 77 94 96  48 82 87  
4 16 48 76  1 16 46  
5 28 32 37  2 0 1  
6 5 55 97  2 24 85  
7 16 90 99  1 53 93  
8 27 90 100  2 52 100  
9 11 14 31  1 4 11  
0 4 31 79   1 8 37  
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; F: Infrequency; Fb: 
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K: 
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5: 
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social 
Introversion 
 
MMPI-2-RF Variables. The three groups were also characterized using all the MMPI-2-RF 
scales. Again, this was done to determine similarities and differences between the two MMPI 
versions assessing MMPI-2 based groups. MANOVA demonstrated overall differences in 
MMPI-2-RF mean scores between the three groups [Wilk’s Lambda; F(15, 431)=21374.5, 
p<.001, Eta2=1.00]. Subsequent ANOVA and Tukey’s b post hoc analyses demonstrated that 
there were significant differences between the groups on all the MMPI-2-RF variables. Table 17 
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presents scale means and standard deviations for each group. Figure 9 illustrates the profiles of 
the three subgroups based on all MMPI-2-RF variables. 
 Table 17 demonstrates that the Method 2-Triad had no elevated validity scales and only 
one scale with high mean scores (scale RC1). The Method 2-Moderate, had one mean score in 
the may be exaggerated range (FBS-r), two high mean scores (RCd and RC2), and one very high 
mean score (RC1). Finally, the Method 2-Pathological had one scale in the may be exaggerated 
range (Fs), two scores in the may be invalid range (F-r and FBS-r), four high mean scores (RCd, 
RC2, RC7 and RC8), and two scales with  very high mean scores (RC1 and RC6).  
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Table 17 
 Method 2 MMPI-2-RF mean, standard deviations, and statistical differences by pain group 
 
  
  M2-      
Triad 
    M2-
Moderate 
M2-
Pathological   F p≤ Eta2 
L-r 63.6 (12.9)a 60.9(13.0)b 60.3(11.7)b  3.0 .050 0.01 
F-r 60.1(8.9)a 79.8(13.0)b 112.0(9.7)c  723.0 .001 0.77 
Fp-r 50.1(9.1)a 55.6(10.7)b 77.1(17.7)c  165.5 .001 0.43 
Fs 54.8(11.2)a 70.2(17.1)b 89.9(17.1)c  164.4 .001 0.43 
FBS-r 64.1(9.6)a 81.6(11.3)b 91.7(11.4)c  217.7 .001 0.50 
K-r 51.9(10.2)a 43.8(9.1)b 36.7(7.1)c  92.9 .001 0.30 
RCd 50.7(7.8)a 66.7(7.5)b 77.6(5.8)c  459.3 .001 0.68 
RC1 66.6(6.7)a 79.1(9.6)b 88.0(8.7)c  204.9 .001 0.48 
RC2 56.0(8.8)a 70.4(10.4)a 77.9(11.9)b  149.9 .001 0.40 
RC3 40.7(12.5)a 52.1(11.0)b 61.6(11.8)c  33.9 .001 0.13 
RC4 46.9(10.0)a 50.1(10.4)b 56.7(12.1)c  27.5 .001 0.11 
RC6 51.3(10.4)a 57.1(11.1)b 80.1(15.8)c  195.5 .001 0.47 
RC7 45.3(8.7)a 56.6(10.3)b 72.3(10.1)c  245.9 .001 0.53 
RC8 48.7(8.7)a 56.3(10.9)b 75.4(12.0)c  217.2 .001 0.50 
RC9 42.6(9.6)a 44.7(9.6)a 51.1(9.8)b   27.2 .001 0.11 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile . F-r: Infrequency 
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r: 
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9: 
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4: 
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant 
Experiences; RC9: Hypomanic Activation. 
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Figure 9.  Method 2 illustration of the profiles of the three-cluster solution described by 
theMMPI-2-RF scales 
 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; . F-r: Infrequency 
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r: 
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9: 
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4: 
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant 
Experiences; RC9: Hypomanic Activation. 
 
 As can be seen in Table 18, the Method 2-Pathological had significantly more patients 
scoring at the may be exaggerated and maybe invalid ranges than the Method 2-Moderate; and, 
in turn, the Method 2-Moderate had more patients in the same ranges than the Method 2-Triad. 
Exceptions were scales L-r, K-r where all groups had similar number of subjects with elevations. 
Similarly, all groups differed in the RC scales. While 66% of patients in the Method 2-Triad 
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scored high on RC1, the Method 2-Moderate and the Method 2-Pathological had more than 95% 
of patients with high mean scores on the same scale. The Method 2-Moderate and the Method 2-
Pathological differences can be seen at higher RC1scores. The Method 2-Pathological had 85% 
patients with very high mean scores while Method 2-Moderate had 46%. The most noticeable 
differences between the groups in the RC scales were in RC7 and RC8, where the Method 2-
Triad had less than 5%, the Method 2-Moderate has about 20% and the Method 2-Pathological 
has more than 75% of patients with high mean scores  
Table 18        
Method 2 percentage of cases that fall above the selected cutoff per group by MMPI-2-RF variable 
 May be exaggerated    May be invalid  
Scale 
M2-
Triad 
M2-
Moderate 
M2-
Pathological  
     M2-
Triad 
M2-
Moderate 
M2-
Pathological  
F-r 1 16 95  0 7 90  
Fp-r 4 8 37  1 4 37  
Fs 4 31 69  2 16 57  
FBS-r 8 64 88  0 21 54  
L-r 31 25 24  16 7 6  
K-r 11 1 0   0 0 0  
 High scores  Very high scores  
  M2-Triad 
M2-
Moderate 
M2-
Pathological  
     M2-
Triad 
M2-
Moderate 
M2-
Pathological  
RCd 3 63 96  0 4 47  
RC1 66 96 99  4 46 85  
RC2 22 75 85  1 22 53  
RC3 20 20 51  0 1 3  
RC4 7 11 30  0 1 2  
RC6 16 27 85  2 3 51  
RC7 4 23 77  0 2 30  
RC8 2 22 80  0 3 33  
RC9 3 4 8   1 0 2  
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; . F-r: Infrequency 
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r: 
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9: 
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4: 
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant 
Experiences; RC9: Hypomanic Activation. 
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Non-MMPI Characteristics of Pain Clusters 
Demographics. Differences between the three subgroups in demographics were tested using 
ANOVA or Chi squared analysis where appropriate and Tukey’s post hoc analysis was 
conducted when necessary. Table 19 presents demographic data by subgroup. The Method 2-
Triad patients were significantly more educated than the Method 2-Moderate and Method 2-
Pathological patients. The Method 2-Triad and Method 2-Moderate had more Caucasians than 
the Method 2-Pathological. Subgroups did not differ in any other demographic variables. Odd 
ratios analysis indicated that the Method 2-Pathological subgroup was 2.3 (95% C.I. = 2.4-2.3) 
less likely to be Caucasian than the other subgroups. 
Table 19 
 Method 2 demographic characteristics by pain group 
 
  
       M2- 
  Triad 
      M2-    
Moderate 
M2-
Pathological   F p≤ Eta2 
  M(sd) M(sd) M(sd)         
Age 42.5 (9.0) 42.5 (8.8) 42.4(8.2)  0.1 NS 0.00 
Education 12.3 (2.5)a 11.6 (2.4)b 11.4 (2.5)b  6.4 .002 0.02 
Time since Injury  34.0 (27.9) 40.7 (30.9) 39.5 (27.7)   2.9 .055 0.01 
  (%) (%) (%)   X2 p≤  
Gender (male) 58.3 65.3 68.7  4.1 NS  
Race (white)  71.1a 70.9a 51.3b   28.9 .001  
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile. 
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
 
Injury Severity. ANOVA demonstrated that there were no differences in Injury Severity mean 
scores between the Method 2-Triad (M = .82; sd = 1.1), M2-Moderate (M = .85; sd = 1.2), and 
Method 2-Pathological (M = .72; sd = 1.1)[ F (1, 583) = 0.06, p > .05, Eta2=0.01]. Table 20 
presents the injury and symptom characteristics of the sample as a function of group 
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membership. Differences between the three subgroups in injury/symptom characteristics were 
tested using Chi squared analysis. As can be seen, subgroups differed in the number of head pain 
complaints. Method 2-Moderate had significantly more participants than Method 2-Triad and 
Method 2-Pathological with head pain complains. Subgroups did not differ in other injury type, 
location, or etiology variable.  
Table 20 
Method 2 percentage of patients with specific Injury/Symptom characteristics by pain group 
 
    M2-
Triad 
M2-
Moderate 
M2-
Pathological 
X2 p< 
Primary back/spine injury 91.6 88.4 87.3 1.8 NS 
Head injury in accident 9.4 10.8 10.7 0.2 NS 
Other Pain symptoms / area of 
body 
     
Head 23.3b 35.1a 27.3b 7.4 .025 
Chest / abdomen 5.0 6.4 7.3 0.8 NS 
Upper extremity 41.7 39.8 38.7 0.4 NS 
Lower extremity 68.3 70.5 63.3 2.2 NS 
Spine Findings      
any spine findings 40.0 40.2 34.7 1.4 NS 
degenerative disc/spine  20.0 20.7 19.3 0.1 NS 
herniated nucleus pulposus 5.6 5.2 4.0 0.5 NS 
disc bulge/protrusion 26.1 26.3 22.7 0.7 NS 
neural impingement 2.8 4.8 3.3 1.3 NS 
Spinal Surgery      
discectomy / fusion 26.1 35.5 30.7 4.2 NS 
decompression/laminectomy 11.7 15.1 20.0 4.4 NS 
Other pain diagnoses      
Complex regional pain syndrome 2.2 2.4 4.0 1.2 NS 
Fibromyalgia 2.8 2.0 2.7 0.3 NS 
Myofascial pain syndrome 1.7 3.6 6.7 5.7 NS 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile. 
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
 
Legal Status. Table 21 presents the legal status of the sample as a function of group 
membership. Differences between the three subgroups in legal characteristics were tested using 
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Chi squared analysis. Groups differed only in the type of legal claim. Method 2-Moderate had 
less patients claiming workers compensation than the Method 2-Triad and Method 2-
Pathological. The Method 2-Triad and Method 2-Pathological did not differ on this variable. 
Odds ratio analysis indicated that the Method 2-Moderate was 1.4 (95% CI = 1.4-1.3) and 3.3 
(95% CI = 3.4-3.2) less likely to be involved in Workers Compensation than the Method 2-Triad 
and Method 2-Pathological, respectively.  
Table 21 
Method 2 percentage of patients per group by legal status. 
            
      
     M2-
Triad 
       M2-
Moderate 
  M2-
Pathological   
 % % % X2 p= 
Status of legal 
representation      
No Attorney 34.4 22.7 31.3 
8.6 NS 
Represented by 
attorney 50.6 62.5 53.3 
Attorney status 
unknown 15.0 14.7 15.3 
Referral source      
doctor 30.6 25.5 27.3 
14.4 NS case manager / adjuster 48.9 45.4 54.0 attorney 3.9 3.6 4.7 
district attorney 15.6 25.5 13.3 
Claim type    
16.3 .012 
workers compensation 83.9 ab 79.3 b 92.7 a 
personal injury 14.4 19.9 6.7 
disability 0.6 0.0 0.7 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile. 
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
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Malingering Diagnosis. Table 22 presents the malingering diagnosis of the sample as a 
function of group membership. Differences between the three subgroups in malingering 
diagnosis were tested using Chi squared analysis. The three subgroups differed significantly in 
the status of the malingering diagnosis in MPRDa [X2(4,583) = 104.5, p< .001].More than half 
(56-71%) of patients in the Method 2-Pathological were formally diagnosed as malingering 
compared to 31-42 % patients in the Method 2-Moderate and 18% of Method 2-Triad patients.  
Odd ratios analysis indicated that the Method 2-Pathological was 25.1 times (95% C.I. = 
25.3-25.0) more likely to be MPRD than Method 2-Triad subgroup when not using the MMPI 
variables as malingering indicators. Similarly, Method 2-Pathological was 8.1 times (95% C.I. = 
8.2-7.9) more likely to be MPRD than Method 2-Moderate subgroup when not using the MMPI 
variables as malingering indicators. The Method 2-Moderate was 3.1 times (95% C.I. = 8.2-7.9) 
more likely to be MPRD than Method 2-Triad subgroup when not using the MMPI variables as 
malingering indicators. When the MMPI variables were used as indicators the odd ratio to be 
MPRD increased to 218.4 (95% C.I. = 219.5-217.4) for the Method 2-Pathological to the 
Method 2-Triad, to 34.7 (95% C.I. = 35.7-33.6) for Method 2-Pathological to Method 2-
Moderate. The likelihood to be MPRD for the Method 2-Moderate increased to 6.3 (95% C.I. = 
6.4-6.2) when compared to the Method 2-Triad. 
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Table 22 
Method 2 malingering status by pain group 
 
Method 2 MPRDa status by subgroup 
  
    M2-
Triad 
M2-
Moderate 
M2-
Pathological    
  % % % X2 p< 
Not MPRD 58.9a 35.5b 11.3c 
92.4 .001 Possible MPRD 23.3 32.7 32.7 Probable MPRD 13.3 25.9 41.3 
Definite MPRD 4.4 6.0 14.7 
All MPRD 17.7 31.9 56.0     
Method 2 MPRDb status by subgroup 
  
    M2-
Triad 
M2-
Moderate 
M2-
Pathological    
  % % % X2 p< 
Not MPRD 54.0a 19.2b 1.0c 
163.7            .001 Possible MPRD 26.7 38.2 28.7 Probable MPRD 13.9 36.7 56.0 
Definite MPRD 4.4 6.0 14.7 
All MPRD 18.3 42.7 70.7  
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with 
a Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile. 
 MPRDa: Malingered Pain Related Disability not including the MMPI-2 variables 
 MMPIb: Malingered Pain Related Disability including the MMPI-2 variables
 
Pain Report and Outcome. Differences in pain report and predictors of outcome were 
determined by comparing current, best, and worst pain as well as catastrophization and 
functional disability among the three subgroups. Differences between the three groups in pain 
perception, PCS and PDI scores were tested using ANOVA.  Pain perception data was available 
for all patients. PCS scores were available for 38 participants from the Method 2-Triad subgroup, 
59 participants from the Method 2-Moderate subgroup and for 41 participants from the Method 
2-Pathological subgroup. PDI data was available for 61 participants from the Method 2-Triad 
subgroup, 94 participants from the Method 2-Moderate subgroup and for 56 participants from the 
Method 2-Pathological subgroup.  
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Table 23 presents data for these variables by group. There was a significant group effect for 
“current” pain rating with Method 2-Triad reporting less subjective least amount of pain than the 
Method 2-Pathological. The Method 2-Moderate did not differ from the Method 2-Triad or the 
Method 2-Pathological in current pain ratings. Moreover, results showed that those in Method 2-
Pathological had significantly higher mean scores than Method 2-Moderate, and Method 2-
Moderate had significantly higher mean scores than Method 2-Triad on the PC and PDI scales. 
Table 23 
Method 2 current, best and worst pain, PCS and PDI scores as a function of pain 
group 
        
  
M2-Triad 
M(sd) 
  M2-Moderate 
M(sd) 
M2-Pathological 
M(sd) F P<  Eta2 
Current Pain 6.2 (1.9)a 6.3 (1.9)ab 6.9 (2.0)b 3.5 .032 0.03 
Best Pain 4.6 (2.0) 5.1 (2.2) 5.4 (2.3) 2.9 NS 0.02 
Worst Pain 9.3 (1.1) 9.3 (1.3) 9.1 (1.6) 0.2 NS 0.01 
PCS  64.2(16.0)a 74.8(12.7)b 84.6(10.2)c 24.2 .001 0.26 
PDI 46.0(15.4)a 52.1(9.9)b 61.6(8.9)c 13.5 .001 0.12 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile.PCS = Pain 
Catastrophizing Scale; PDI = Pain Disability Index 
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
 
Method 2 Summary and Conclusions 
After running several exploratory two-steps cluster analyses using the MMPI-2 scales F, Fb, 
Fp, FBS, L and K and the ten clinical scales, two and three-cluster solutions were determined to 
be appropriate solutions when using Method 2. Nevertheless, the three-cluster solution was 
selected to be the “best” solution because it provided information over the two-cluster solution 
and thus, it was further characterized. 
The three-cluster solution was distinguished by three homogeneous subgroups that differed 
considerably in the number and type of MMPI-2 scales elevated as well as the number of patients 
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with scale elevations.  Method 2-Triad elevated on scales 1, 2 and 3 and did not show over-
reporting of symptoms. Method 2-Moderate elevated on one validity scale (FBS) and six clinical 
(scales 1, 2,3,6,7, and 8). Finally, Method 2-Pathological was characterized by mean elevations 
on all over-reporting validity scales (i.e. F, Fp, Fb and FBS) and on eight out of the ten clinical 
scales (i.e.1,2,3,4,6,7,8 and 0). Thus, when compared to Method 1, Method 2-Triad demonstrated 
a lower profile (lower scores on the same elevated scales) than the Method 1-Triad; Method 2-
Pathological showed a higher profile (higher scores on the same elevated scales) than the 
Method 1-Pathological; and there was the existence of a Method 2-Moderate subgroup that 
likely comprise those patients that scored in the upper end of the two-cluster Method 1-Triad 
profile and those that scored in the lower end of the two-cluster Method 1-Pathological profile. 
Thus, in addition to the two profiles found with Method 1, using all MMPI-2 variables, as used 
in Method 2, was able to consistently identify a new group (Method 2-Moderate) of patients that 
reported moderate psychological difficulties. 
When the three subgroups were compared on the MMPI-2-RF scales, these had similar 
characteristics as the MMPI-2; that is, they differ in mean score and proportion of subjects with 
elevated scales. However, MMPI-2-RF scales (RC3 and RC4) were less likely to be elevated by 
the Method 2-Moderate and Method 2-Pathological even when they were elevated in the MMPI-
2. In fact, these were shown insensitive to “Moderate” profiles. 
As Method 1, the three subgroups were also compared in demographic, pain report, 
injury/symptom characteristics, legal status and malingering diagnosis. Differences were found 
in education, current pain report, head complains, claim type and malingering diagnosis. Thus, 
again, subgroup membership was not conditioned to the type/severity of the injury. Method 2-
Triad was described as a highly educated group, which reported low current pain. Method 2-
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Triad also had the lowest number of patients diagnosed as malingerers. Method 2-Moderate was 
described as a low educated group, with the highest proportion of patients with head complains. 
Method 2-Moderate had the higher number of patients with personal injury claims and these 
patients were 3 times more likely to be diagnosed as malingerers than those in the Method 2-
Triad. Finally, Method 2-Pathological was described as low educated and diverse than the other 
subgroups as it had the lowest grade completed and proportion of Caucasians. Finally, the 
Method 2-Pathological was 25 and 8 times more likely to be diagnosed as malingering than the 
Method 2-Triad and Method 2-Moderate respectively, when the MMPI variables were not used 
as malingering indicators. The likelihood increased significantly when the MMPI variables were 
used as indicators. 
 In terms of predictors of outcome, Method 2-Triad reported the lowest level of current 
pain, catastrophization and perceived disability followed by Method 2-Moderate and then the 
Method 2-Pathological. Thus, the results again supported the idea that MMPI-2 Triad profiles 
tend to report better outcome than MMPI-2 Pathological profiles (as found in Part 1). Moreover, 
it can be concluded that the new Moderate profile reports poor outcome levels but these levels 
are lower than the Pathological profile. 
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Method 3: MMPI-2-RF Clustering Method 
Defining the Number of Clusters  
Method 3 applied an exploratory two steps cluster analysis using the MMPI-2-RF validity 
scales F-r, Fp-r, Fs, FBS-r, L-r and K-r and the nine RC scales.  Again, SPSS autoclustering was 
used to determine the best solution. Like the previous two methods the data was first ordered 
ascendingly by patient’s ID number before running the autoclustering analysis. When the data 
was ordered this way it was determined the optimal number of clusters was the two-cluster 
solution. In support of the two-cluster solution, there was a dramatic jump in variance explained 
from one (BIC = 4865.0) to two (BIC = 3901.6; RDM = 2.7) cluster solutions with only modest 
increases when three (BIC = 3665.6; RDM = 1.6) and four-clusters (BIC =3578.8; RDM = 1.7) 
solutions were isolated.  
When sorting the full data set descendingly by patient’s ID number, it was determined 
that the optimal number of clusters was the three-cluster solution. In support of the three cluster 
solution, the BIC showed a dramatic jump in variance explained from one (BIC = 4865.0) to two 
(BIC = 3846.9; RDM = 2.8) and a similar dramatic jump from two to three (BIC = 3594.0; RDM 
= 2.4) cluster solution with only modest increases when four (BIC = 3595.6; RDM = 1.2) and 
five clusters (BIC =3622.9; RDM = 1.0) solutions were isolated.   
Selection of Best Cluster Solution. To select the “best” cluster solution, 50 cluster analyses 
were all run after randomly resorting the data set using 70% of the total sample. Out of the 50 
runs, BIC determined that the two cluster solution was the most adequate 25 times (50 %), the 
three-cluster solution was the most adequate 23 times (46 %) and a four-cluster solution was 
most adequate only 2 times (4 %). Results using Binomial Tests showed no significant 
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differences between observed proportion and the expected proportion between the appearance of 
the two and three solutions (p > .05). The two-cluster and the three-cluster solutions appeared 
significantly more times than the four-cluster solution (p< .001). This suggests that the two-
cluster solution and the three-cluster solution are equally adequate for the current sample using 
Method 3. As with Method 2, since the two and a the three-cluster solutions seemed to be 
adequate, the three-cluster solution was selected as the “best fit” because it provides more 
theoretical information over the two cluster-solution.  
The two subgroups found in the two-cluster solution were: a group (Method 3-Solution 2-A) 
with 277 participants and a group (Method 3- Solution 2-B) with 174 participants. The three 
subgroups identified in the three-cluster solution were: a group (Method 3-Solution 3-A) with 
143 participants, a group (Method 3-Solution 3-B) with 180 participants and a group (Method 3-
Solution 3-C) with 128 participants. Using crosstab analysis it was determined that all subjects 
classified as in subgroups Method 3-Solution 3-A were originally in subgroup Method 3-Solution 
2-A. Similarly, all subjects classified as Method 3-Solution 3-C were originally in subgroup 
Method 3-Solution 2-B. Subgroup Method 3-Solution 3-B was composed by 74.4% of subjects 
that were in subgroup Method 3-Solution 2-A and 25.6% of subjects that were in Method 3-
Solution 2-B.  
Figure 10 presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster 
and the three-cluster solutions. As can be seen, when compared to the two-cluster solution, the 
three-cluster solution presents Somatic and Pathological profiles that differ substantially in the 
elevation of scores. Moreover, the three-cluster profile demonstrated the existence of a 
Depressed subgroup  due to its elevations on the demoralization, somatic and depressed scales in 
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addition to FBS profile that is comprised of those patients that scored in the upper end of the 
two-cluster Somatic. 
Therefore, since the three-cluster solution provides 1) the most number of groups, 2)  
information about a “Depressed” subgroup, and 3) creates larger separation between the Somatic 
and Pathological profiles,  it was determined the three-cluster solution was the most 
comprehensive fit for Method 3. As a result, the three subgroups that resulted from this solution 
were further described on a number of MMPI, non-MMPI, pain perception and predictor of 
outcome variables. 
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Figure10  presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster 
and the three-cluster solutions. 
 
Note. F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency 
somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K: Correction 
restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive 
Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional 
Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation. 
 
Comparison of MMPI-2 and MMPI-2-RF Clustering Methods. Before, describing the 
Method 3 subgroups, a crosstab comparison was performed between the MMPI-2 versus the 
MMPI-2-RF methods used  the in classification of pain patients into the subgroups. This was 
done to understand the differences between the tests versions since it was determined that the 
three-cluster solution was the most comprehensive fit for both methods. As can be seen in Table 
24, 85% of the subjects who were classified as Method 3-Somatic were also classified as Method 
2-Triad. Method 3-Depressed was composed of 77% of the subjects classified as Method 2-
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Moderate. Finally, Method 3-Pathological was composed of 88% of subjects that were classified 
as Method 2-Pathological. This demonstrates that although there is an important overlap among 
the classification methods, the methods did not agree for a range of 12-25% of the cases 
depending on the subgroup profile.  
Table 24 
Crosstab on the percentage of cases that overlap between the clustering methods  
  Method 2 
  M2-Triad M2-Moderate M2-Pathological 
  % % % 
 M3-Somatic 85.2 14.8 0.0 
Method 3 M3-Depressed 14.7 77.4 7.9 
 M3-Pathological 0.0 8.9 88.2 
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a 
Moderate profile; M2-Pathological : Method 2 subgroup with a Pathological profile; M2-Somatic: 
Method 2 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a Depressed profile; 
M3-Pathological : Method 3 subgroup with a Pathological profile. 
 
Characterization of Pain Clusters based on all MMPI Variables 
MMPI-2-RF Variables. MANOVA demonstrated overall group differences in the MMPI-2-
RF [Wilk’s Lambda; F(15, 434)=22230.3, p<.001, Eta2=1.00]. Subsequent ANOVA and 
Tukey’s b post hoc analyses demonstrated significant differences between the groups in all the 
MMPI-2-RF variables. Table 25 presents scale means and standard deviations for each group.  
Figure 11 illustrates the subgroup mean profiles. 
Table 25 and Figure 11 show that Method 3-3A subgroup only had high mean scores on 
RC1 (this group will be referred Method 3-Somatic). The Method 3-3B subgroup had one mean 
scores in the may be exaggerated range on FBS-r, and three high mean scores on RCd, RC1 and 
RC2 (this subgroup will be referred as Method 3- Depressed). Finally, Method 3--3B subgroup 
had one scale in the may be exaggerated range on Fp-r, three scores in the may be invalid range 
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on F-r, Fs and FBS-r, four high mean scores on RCd, RC2, RC7 and RC8, and two scales with 
very high mean scores on RC1 and RC6 (this group will be referred as M3-Pathological).  
Table 25 
 Method 3 MMPI-2-RF mean, standard deviations, and statistical differences by pain subgroup 
  
  
M3- 
Somatic 
M3- 
Depressed 
M3- 
Pathological  F p< Eta2 
L-r 65.0 (12.9)a 60.8(11.0)b 59.0 (11.4)b  9.6 .001 0.04 
F-r 59.7(8.5)a 80.2(11.3)b 112.1(9.6)c  935.1 .001 0.81 
Fp-r 48.8(7.8)a 56.8(11.0)b 76.6(17.7)c  176.3 .001 0.44 
Fs 53.6(10.4)a 70.6(15.6)b 90.9(16.9)c  221.2 .001 0.50 
FBS-r 66.3(10.4)a 80.6(12.7)b 91.4(11.3)c  160.5 .001 0.42 
K-r 54.3(8.2)a 41.9(8.3)b 36.3(6.8)c  193.5 .001 0.46 
RCd 51.1(7.8)a 67.0(7.3)b 77.4(6.0)c  475.4 .001 0.68 
RC1 67.3(7.3)a 78.5(9.2)b 88.6(8.7)c  214.1 .001 0.49 
RC2 58.5(9.8)a 69.8(11.8)b 76.8(12.6)c  89.4 .001 0.29 
RC3 47.2(10.7)a 53.9(10.8)b 62.7(11.4)c  67.8 .001 0.23 
RC4 45.1(8.8)a 51.5(10.6)b 56.7(11.8)c  41.7 .001 0.16 
RC6 49.2(8.9)a 58.5(10.5)b 80.2(15.6)c  244.5 .001 0.52 
RC7 43.4(6.7)a 57.9(8.9)b 72.9(9.4)c  415.7 .001 0.65 
RC8 46.6(7.7)a 57.1(8.7)b 76.3(11.5)c  351.8 .001 0.61 
RC9 39.4(6.9)a 46.3(9.9)b 52.2(9.5)c  69.9 .001 0.24 
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F-r: Infrequency 
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r: 
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9: 
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emotions; RC3: Cynism; RC4: 
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant 
Experiences; RC9: Hypomanic Activation. 
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
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Figure  11.  Illustration of the profiles of the three subgroups described by the MMPI-2-
RF scales. 
 
 
Note. M3-Somatic: Method 3 subgroup with a Somatic profile; M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F-r: Infrequency 
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r: 
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9: 
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emotions; RC3: Cynism; RC4: 
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant 
Experiences; RC9: Hypomanic Activation. 
 
As can be seen in Table 26, the Method 3-Pathological also had significantly more 
patients scoring at the may be exaggerated and maybe invalid ranges than the Method 3-
Depressed; and the Method 3-Depressed in turn had more patients in the same ranges than the 
Method 3-Somatic. Interestingly, the Method 3-Pathological had 91% of patients in the F-r may 
be invalid range, compared to 5% of Method 3-Depressed and 0% of Method 3-Somatic. In the 
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under-reporting scales L-r and K-r, Method 3-Somatic had slightly higher number of subjects 
with elevations than the other groups. Differences between the groups were identified in all RC 
scales at both elevation levels. While 66% of patients in Method 3-Somatic scored high on RC1, 
the Method 3-Depressed and Method 3-Pathological had more than 95% of patients with high 
mean scores on scales RC1. The Method 3-Pathological and the Method 3-Depressed differences 
can be seen at higher RC1scores where the Method 3-Pathological had 85% patients with very 
high mean scores while the Method 3-Depressed had 44%. The most noticeable differences 
between the groups in the RC scales were in RC6, RC7 and RC8, where the Method 3-Somatic 
had less than 8%, the Method 3-Depressed has about 25% and the Method 3-Pathological has 
more than 81% of patients with high mean scores. 
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Table 26  
Method 3 percentage of Cases that fall above the selected cutoff per MMPI-RF variable 
 
 May be exaggerated   May be invalid  
Scale 
M3- 
Somatic 
M3- 
Depressed 
M3- 
Pathological  
M3- 
Somatic 
M3- 
Depressed 
M3- 
Pathological  
F-r 0 16 95  0 5 91  
Fp-r 2 11 54  0 0 12  
Fs 2 31 72  1 15 59  
FBS-r 14 62 88  1 22 52  
L-r 38 24 18  18 6 5  
K-r 11 0 0  0 0 0  
 High scores  Very high scores  
  M3- Somatic 
M3- 
Depressed 
M3- 
Pathological  
M3- 
Somatic 
M3- 
Depressed 
M3- 
Pathological  
RCd 4 64 97  0 3 47  
RC1 69 95 99  6 44 85  
RC2 32 72 83  2 24 49  
RC3 11 23 56  0 0 4  
RC4 4 14 29  0 1 2  
RC6 8 32 86  1 3 52  
RC7 0 24 81  0 2 30  
RC8 1 19 84  0 1 34  
RC9 0 6 9  0 1 2  
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F-r: Infrequency 
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r: 
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9: 
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emotions; RC3: Cynicism; RC4: 
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant 
Experiences; RC9: Hypomanic Activation. 
 
MMPI-2 Variables. The three subgroups were also characterized using the all MMPI-2 
scales. Once more, this was done to determine similarities and differences between the two 
MMPI versions, but this time assessing MMPI-2-RF method to determine the subgroups. 
MANOVA demonstrated overall differences in MMPI-2 mean scores between the three groups 
[Wilk’s Lambda; F(16, 430) = 8320.8, p<.001, Eta2=1.0). Subsequent ANOVA and Tukey’s b 
post hoc analyses demonstrated that there are significant differences between the three groups in 
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all the MMPI-2 variables. Table 27 presents scales mean and standard deviations for each group.  
Figure 11 illustrates the three subgroup mean profiles based on the MMPI-2 variables. 
Table 27 and Figure 12 show that Method 3-Somatic had no elevated validity scales, one 
scale with high mean scores (scale 2) and two scales with a very high mean score (scales 1 and 
3) demonstrating a Triad profile. Method3-Depressed had one mean scores in the may be 
exaggerated range (FBS), two high mean scores (scale 6 and 7), and four scales with very high 
mean scores (scales 1, 2, 3 and 8) demonstrating a Moderate profile. Finally, Method 3-
Pathological had three scores in the may be invalid range (scale F, Fb and FBS), two high mean 
scores (scales 4 and 0), and six scales with very high mean scores (scales 1, 2, 3,6, 7 and 8) 
demonstrating a Pathological profile.  
 
90 
 
Table 27 
MMPI-2 scales means and standard deviations by Method 3 groups 
  
M3- 
Somatic 
M3- 
Moderate 
M3- 
Pathological   F p< Eta2 
  M(sd) M(sd) M(sd)      
L 65.9(12.2)a 59.6(10.5)b 56.4 (10.1)c  27.1 .001 0.11 
F 52.1(7.0)a 64.5(9.8)b 89.7(16.4)c  378.5 .001 0.63 
Fb 49.2(7.3)a 69.7(14.2)b 100.2(17.4)c  484.4 .001 0.69 
Fp 50.8(10.4)a 54.6(11.1)b 67.8(16.9)c  65.5 .001 0.23 
FBS 70.9(11.1)a 84.5(14.2)b 93.2(11.0)c  112.4 .001 0.34 
K 58.8(8.7)a 46.7(9.3)b 38.7(6.6)c  197.2 .001 0.47 
1  77.3(9.4)a 82.8(10.4)b 87.8(8.6)c  40.2 .001 0.15 
2 73.7(11.4)a 84.8(11.0)b 90.0(9.2)c  114.1 .001 0.34 
3 78.8(13.0)a 86.7(16.8)b 87.2(11.9)b  15.4 .001 0.07 
4 57.0(9.5)a 49.4(8.4)b 71.7(11.4)c  58.0 .001 0.21 
5 49.2(10.6)a 49.4(8.4)a 51.9(8.8)b  3.7 .025 0.02 
6 51.7(10.1)a 66.8(12.7)b 88.6(14.4)c  295.9 .001 0.57 
7 59.5(10.5)a 74.4(10.7)b 87.8(10.0)c  247.9 .001 0.53 
8 61.0(8.7)a 74.9(10.5)b 96.3(10.6)c  424.4 .001 0.66 
9 49.2(8.4)a 52.9(10.4)a 60.1(11.3)b  40.5 .001 0.15 
0 50.2(8.1)a 60.2(9.9)b 70.9(8.9)c   176.2 .001 0.44 
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F: Infrequency; Fb: 
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K: 
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5: 
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social 
Introversion 
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
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Figure  12.  Illustration of the profiles of the three subgroups described by the MMPI-2 
scales. 
 
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F: Infrequency; Fb: 
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K: 
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5: 
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social 
Introversion 
 
As can be seen in Table 28, the Method 3-Pathological had significantly more patients 
scoring at the may be exaggerated and maybe invalid ranges on all the validity scales than 
Method 3-Somatic and Method 3-Depressed. The most noticeable difference between all 
subgroups was on scale Fb where the Method 3-Pathological had 89% of patients scoring at may 
be exaggerated range compared to 0% in the other two groups. Method 3-Somatic and Method 3-
Depressed had similar proportion of patients on scales F, Fb and Fp. On FBS, Method 3-
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Depressed had a higher proportion of patients than the Method 3-Somatic in the may be 
exaggerated and may be invalid ranges. On the clinical scales, the most noticeable differences 
were in scales 7 and 8 where the Method 3-Somatic had less than 10%, the Method 3-Depressed 
had about 50% and the Method 3-Pathological had more than 90% of patients with very high 
mean scores. The Method 3-Somatic, Method 3-Depressed and Method 3-Pathological had 
similar number of patients with high mean scores on clinical scales 1, 2, and 3. However, Method 
3-Depressed and Method 3-Pathological had more patients than the Method 3-Somatic with very 
high mean scores on the same scales. 
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Table 28      
Method 3 percentage of Cases that fall above the selected cutoff per M1-Pathologicaly MMPI-2 
variable 
 
 Maybe exaggerated Maybe invalid 
 
M3- 
Somatic 
M3- 
Moderate 
M3- 
Pathological 
M3- 
Somatic 
M3- 
Moderate 
M3- 
Pathological 
Scale       
F 1 30 91 0 2 43 
Fb 0 0 89 0 0 78 
Fp 2 4 21 1 1 12 
FBS 26 67 94 1 15 28 
L 39 18 11 13 5 2 
K - - - 22 3 0 
 High scores Very high scores 
 M3- Somatic 
M3- 
Moderate 
M3- 
Pathological 
M3- 
Somatic 
M3- 
Moderate 
M3- 
Pathological 
1 92 96 99 67 79 91 
2 71 94 99 39 85 98 
3 85 89 96 62 75 88 
4 22 50 73 4 20 40 
5 11 2 9 2 0 1 
6 8 57 97 2 26 81 
7 25 85 99 8 51 90 
8 39 84 100 5 54 99 
9 8 15 34 0 4 12 
0 4 31 79 1 8 37 
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F: Infrequency; Fb: 
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K: 
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5: 
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social 
Introversion 
 
Non-MMPI Characteristics of Pain Clusters 
Demographics . Differences between the three subgroups in demographic were tested using 
ANOVA or Chi squared analysis where appropriate and Tukey’s post hoc analysis was 
conducted when necessary. Table 29 presents demographic data by subgroup.  There was a 
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significant group effect for education and race with the Method 3-Somatic having higher 
education and Method 3-Pathological having less percentage of Caucasians than the other 
groups. Groups did not differ on any other demographic variables. Odd ratios analysis indicated 
that the Method 3-Pathological subgroup was 2.6 (95% C.I. = 2.6-2.5)  and 2.3 (95% C.I. = 2.3-
2.2 ) less likely to be Caucasian than the Method 3-Somatic and Method 3-Depressed subgroups, 
respectively. 
Table 29 
 Method 3 Demographic characteristics by MMPI-2-RF based subgroups 
        
  
M3- 
Somatic 
M3- 
Moderate 
M3- 
Pathological     
  M(sd) M(sd) M(sd)   F p≤ Eta2 
Age 43.5(8.8) 42.7 (9.0) 43.1(8.2)  0.3 NS 0.00 
Education 12.3(2.5)a 11.7 (2.5)b 11.6 (2.6)b  3.4 .034 0.02 
Time since Injury 35.6(28.7) 41.5 (30.3) 40.1 (27.3)   2.9 NS 0.01 
 (%) (%) (%)   X2 p≤  
Gender (male) 56.6 67.8 64.8  4.4 NS  
Race (white) 73.3a 70.6a 51.6b   19.2 .014  
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .  
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
 
Injury Severity. ANOVA demonstrated that there were no differences in Injury Severity 
mean scores between Method 3-Somatic (M = .82; sd = 1.1), Method 3-Depressed (M = .85; sd = 
1.2), and Method 3-Pathological (M = .72; sd = 1.1) [F (1, 583) = 0.06, p > .05, Eta2=0.01]. 
Table 30 presents the injury and symptom characteristics of the sample as a function of group 
membership. Differences between the three groups in injury/symptom characteristics were tested 
using Chi squared analysis. As can be seen, groups did not differ in other injury type, location, or 
etiology variable.  
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Table 30 
Percentage of patients with specific Injury/Symptom characteristics by pain group 
  M3- 
Somatic 
M3- 
Moderate 
M3- 
Pathological X2 p< 
Primary back/spine injury 89.4 93.0 87.5 2.3 NS 
Head injury in accident 10.6 11.9 14.8 2.3 NS 
Other Pain symptoms / area of body      
Head 28.2 40.8 31.0 1.4 NS 
Chest / abdomen 37.0 22.2 40.7 2.4 NS 
Upper extremity 40.1 31.9 28.0 0.1 NS 
Lower extremity 39.3 34.1 26.6 2.9 NS 
Spine Findings      
any spine findings 39.2 35.3 25.5 2.7 NS 
degenerative disc/spine  36.1 36.1 27.8 1.4 NS 
herniated nucleus pulposus 32.0 44.0 24.0 1.9 NS 
disc bulge/protrusion 42.7 33.6 23.8 2.2 NS 
neural impingement 36.8 31.6 31.6 0.1 NS 
Spinal Surgery      
discectomy / fusion 44.1 28.7 27.2 1.5 NS 
decompression/laminectomy 14.4 13.3 21.1 3.6 NS 
Other pain diagnoses      
Complex regional pain syndrome 2.8 2.1 3.1 0.3 NS 
Fibromyalgia 1.7 3.5 2.3 1.1 NS 
Myofascial pain syndrome 5.0 1.4 5.5 3.7 NS 
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .  
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
 
Legal Status. Table 31 presents the legal status of the sample as a function of group 
membership. Differences between the three subgroups in legal characteristics were tested using 
Chi squared analysis. Groups did not differ in the status of legal representation or referral source. 
Groups differed in the type of legal claim. Method 3-Depressed had less patients claiming 
workers compensation than Method 3-Somatic and Method 3-Pathological. Method 3-Somatic 
and Method 3-Pathological did not differ on this variable. Odds ratio analysis indicated that the 
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M3-Depressed was 1.4 (95% CI = 1.5-1.4) and 2.9 (95% CI = 3.1-2.8) less likely to be involved 
in Workers Compensation than the Method 3-Somatic and Method 3-Pathological, respectively. 
Table 31      
Method 3 medico-legal characteristics of the chronic pain sample as a function of Cluster 
membership. 
      
M3- 
Somatic 
M3- 
Moderate 
M3- 
Pathological   
 % % % X2 p= 
Status of legal representation      
No Attorney 26.1 36.4 31.3 
4.1 NS Represented by attorney 61.1 51.7 55.5 
Attorney status unknown 12.8 11.9 13.3 
Referral source      
doctor 23.3 23.1 33.6 
14.9 NS case manager / adjuster 45.0 52.4 49.2 attorney 4.4 2.8 5.5 
district attorney 26.1 21.0 11.7 
Claim type    
16.3 .04 
workers compensation 82.5ab 76.7 b 90.6 a 
personal injury 17.5 21.7 9.4 
disability 0.0 1.1 0.0 
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a 
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .  
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
 
Malingering Diagnosis. Table 32 presents the malingering diagnosis of the sample as a 
function of group membership. The three subgroups differed significantly in the status of the 
malingering diagnosis in MPRD [X2(4,583) = 135.3, p< .001]. More than half (59-71%) of 
patients in the Method 3-Pathological were formally diagnosed as malingering compared to 37-
43 % patients in the Method 3-Depressed and 18-20% of Method 3-Somatic patients.  
Odd ratios analysis indicated that the Method 3-Pathological was 34.7 times (95% C.I. = 
34.9-34.5) more likely to be MPRD than Method 3-Somatic subgroup when not using the MMPI 
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variables as malingering indicators. Similarly, Method 3-Pathological was 9.4 times (95% C.I. = 
9.7-9.2) more likely to be MPRD than Method 3-Depressed subgroup when not using the MMPI 
variables as malingering indicators. The Method 3-Depressed was 3.7 times (95% C.I. = 3.8-3.6) 
more likely to be MPRD than Method 3-Somatic subgroup when not using the MMPI variables 
as malingering indicators. When the MMPI variables were used as indicators the odd ratio to be 
MPRD increased to 132.1 (95% C.I. = 133.1-131.4) for the Method 3-Pathological to the 
Method 3-Somatic, to 18.2 (95% C.I. = 19.3-17.1) for Method 3-Pathological to Method 3-
Depressed. The likelihood to be MPRD for the Method 3-Depressed increased to 7.3 (95% C.I. = 
7.4-7.1) when compared to the M3-Somatic. 
 
Table 32 
Method 3 malingering status by pain group 
 
Method 3 MPRDa status by subgroup 
  
    M3-
Somatic 
M3-
Depressed 
M3-
Pathological    
  % % % X2 p< 
Not MPRD 56.0a 28.3b 7.0c 
85.0 .001 Possible MPRD 24.5 34.4 33.6 Probable MPRD 14.7 30.0 45.3 
Definite MPRD 4.9 7.2 14.1 
All MPRD 19.6 37.2 59.4     
Method 3 MPRDb status by subgroup 
  
    M3-
Somatic 
M3-
Depressed 
M3-
Pathological    
  % % % X2 p< 
Not MPRD 49.7a 12.8b 0.0c 
135.3  .001 Possible MPRD 28.7 42.8 28.9 Probable MPRD 16.8 37.2 57.0 
Definite MPRD 4.9 7.2 14.1 
All MPRD 18.3 42.7 71.1   
Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup 
with a Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .  
MPRDa: Malingered Pain Related Disability not including the MMPI-2 variables 
 MMPIb: Malingered Pain Related Disability including the MMPI-2 variables
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
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Pain Report and Outcome. To determine differences in report of pain and outcome, levels of 
current pain, best pain and worst pain, as well as catastrophization and functional capacity were 
compared among the three subgroups. Pain report was available for all patients. PCS scores were 
available for 56 Method 3-Somatic patients, 42 Method 3-Depressed participants and 43 Method 
3-Pathological participants. PDI data was available for 68 Method 3-Somatic participants, 88 
Method 3-Depressed participants and 58 Method 3-Pathological participants. Table 33 presents 
data for these variables by group. There was a significant group effect for “current” pain rating 
with Method 3-Somatic reporting less subjective least amount of pain than the Method 3-
Pathological. The Method 3-Depressed did not differ from the Method 3-Somatic or the Method 
3-Pathological in current pain ratings. Moreover, results showed that those in Method 3-
Pathological had significantly higher mean scores than Method 3-Depressed, and Method 3-
Depressed had significantly higher mean scores than Method 3-Somatic on the PC and PDI 
scales. 
Table 33 
PCS and PDI scores as a function of pain group 
        
  
M3- 
Somatic 
M3- 
Depressed 
M3- 
Pathological 
    
 M(sd) M(sd) M(sd)  F p≤  Eta2 
Current Pain 6.2(2.0) 6.5(1.9) 6.8 (1.9)  2.0 NS 0.01 
Best Pain 4.6 (2.1)a 4.7(2.2)ab 5.3(2.3)b  2.7 .04 0.02 
Worst Pain 9.3(1.5) 9.3(1.0) 9.2(1.5)  0.2 NS 0.00 
PCS  63.6(14.4)a 76.5(13.4)b 83.8(10.1)c  24.3 .001 0.28 
PDI 48.8(12.7)a 50.3(12.7)b 57.2(9.0)c  8.7 .001 0.08 
Note. Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup 
with a Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .  
abc row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test. 
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Method 3 Summary and Conclusions 
An exploratory two steps cluster analysis was conducted using the MMPI-2 scales F-r, 
Fp-r, Fs, FBS-r, L-r and K-r and the nine RC scales. As Method 2, two and three cluster 
solutions were determined to be appropriate solutions for the current sample. The three cluster 
solution was selected to be further described because it provides valuable information over the 
two-cluster solution.  The three cluster solution was characterized by three homogeneous groups 
that differed drastically in the number and type of MMPI-2-RF scales elevated as well as the 
number of patients with elevation.  Note that Method 3 classification agreed with Method 2 
classification for about 75% of the cases demonstrating that there was an important overlap in 
how the MMPI-2-RF and the MMPI-2 variables classify participants into subgroups.  
The first subgroup was called Method 3-Somatic because it showed elevations only on 
RC1 and did not show over-reporting of symptoms. The second subgroup was called Method 3-
Depressed because elevated on one validity scale (FBS-r) and on the deception, somatic 
complains and depression scales (RCd, RC1 and RC2). Finally, the last subgroup was called 
Method 3-Pathological because it was characterized by having elevations in all over-reporting 
validity scales (i.e. F-r,Fp-r, Fs, FBS-r) and five out of the nine RC scales (i.e. RCd, 
RC1,RC2,RC7, RC9).  
The three groups also differed in all MMPI-2 scales, demonstrating the relationship 
between the MMPI-2- RF scales and its original counterpart. However, like Method 2, some 
MMPI-2-RF scales (i.e. RC3, RC4 and RC6) were less likely to be elevated by the pain 
subgroups than the MMPI-2 counterparts. The three groups were also different in the Non-MMPI 
variables: level of education, race, and malingering diagnosis. The Method 3-Somatic was 
described as a highly educated group, which had the lowest number of patients diagnosed as 
malingerers. The Method 3-Depressed was described as a low educated group, with the highest 
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proportion of patients with personal injury claims and were 4 times more likely to be diagnosed 
malingerers than Method 3-Somatic. Finally, Method 3-Pathological was described was less 
educated and diverse than the Method 3-Somatic and it was the subgroup with the lowest number 
of Caucasians. Finally, the Method 3-Pathological was 35 and 9 times more likely to be 
diagnosed as malingering than the Method 3-Somatic and Method 3-Depressed respectively, 
when the MMPI variables were not used as malingering indicators. The likelihood increased 
significantly when the MMPI variables were used as indicators. In terms of outcome, Method 3-
Pathological also demonstrated the highest level of catastrophization and perceived disabilities 
followed by the Method 3-Depressed and then the Method 3-Somatic. Thus, the results again 
supported the previously found dose response relationship between subgroup profile elevations 
and malingering and outcome report. 
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CHAPTER VI 
DISCUSSION 
The general purposes of this study were 1) to establish through cluster analysis subgroups 
and profiles from a large pain patient population evaluated in medico-legal settings using the 
MMPI-2 and MMPI-2-RF; 2) to determine the relationship between subgroup membership and 
selected non-MMPI variables, including pain perception and perceived outcome. Exploratory 
two-step cluster analyses were conducted to group the participants using three different methods. 
Method 1 used the MMPI-2 standard clinical scales and the traditional validity scales L, F and K 
to test whether the previously found pain subgroups were also found in the present medico-legal 
sample. Method 2 used all of the MMPI-2 scales to test whether the inclusion of all the available 
scales impacted the number and the characteristics of pain subgroups. Finally, Method 3 used the 
MMPI-2-RF scales to test whether a cluster analysis using these newly developed scales 
influenced the previously found MMPI-2 cluster number and characteristics.  
Method 1 
Result demonstrated that the best natural “fit” for the current sample was the two-cluster 
solution when Method 1 was used. The subgroups presented a Triad (high elevations on scales 1, 
2, and 3) and a Pathological (extremely high elevations on multiple validity and almost all 
clinical scales) profiles. These results are relatively similar to previous cluster analytic 
investigations (i.e. Riley et al., 1993, Block & Ohnmeiss, 2000; Marters et al., 2002), which used 
the same method to cluster pain patients. The only exception is that the current investigation did 
not find a subgroup described by no clinical scale elevations (Normal). 
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Method 2 
When Method 2 was used, the most comprehensive solution was the three-cluster 
solution. This solution found that in addition to a Triad and Pathological subgroups, there was a 
Moderate subgroup. The Moderate subgroup was formed by 49% of patients originally classified 
as Triad using Method 1, and 51% of patients classified as Pathological using Method 1. The 
Moderate subgroup scored in the exaggeration range on FBS and had elevations on most clinical 
scales; though these were not as extreme as the Pathological profile. With the appearance of this 
Moderate subgroup, the Method 2 Triad and Pathological subgroups had more extreme scores 
compared to the Method 1 subgroup counterpart. That is, the Triad subgroup scores were lower 
and the Pathological subgroup scores were higher on all scales compared to their Method 1 
counterparts.  
Method 3 
Finally, using Method 3 the most comprehensive solution was the three-cluster solution, 
which described a Somatic, Depressed, and Pathological profiles. These subgroups were 
described based on their RC elevations (see Tallegen et al., 2003 for more information). The 
Somatic profile was defined based on  elevations on scales that resemble somatization (RC1); the 
Depressed profile was defined based on elevations on scales that resembles demoralization, 
negative mood and somatization (RCd, RC1 and RC2); and the Pathological profile was defined 
based on its multiple clinical elevations (Tallegen et al., 2003). When compared to Method 2, 
85% of Somatic patients were also classified as Triad; 77% of Depressed patients were in the 
Moderate subgroup; and 88% of Pathological patients were classified as Pathological in Method 
2. Thus, MMPI-2-RF subgroups were composed, for the most part, of the same patients that were 
identified in their Method 2 counterpart. 
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MMPI-2 vs. MMPI-2-RF 
Interestingly, the MMPI-2-RF subgroups resembled the MMPI-2 profiles when these 
were described in terms of the MMPI-2 variables. That is, the Somatic group resembled an 
MMPI-2 Triad profile; the Depressed subgroup resembled the MMPI-2 Moderate profile, and 
the Pathological subgroup was similar to the MMPI-2 Pathological profile. However, there are 
some differences between the test versions that are worth noting. For all profiles, there was an 
apparent lack of relationship observed between scale 3 and its RC counterpart (RC3). One 
explanation is that many somatic components of scale 3 are now represented in RC1 and not 
RC3 (Tallegen et al., 2003). In fact, in  three different community and psychiatric samples, 
correlations between scale 3 and RC1 ranged from .60 to .70 while correlations between scale 3 
and RC3 only ranged from .01 to -.20 (Tallegen et al., 2003).  
 The other most identifiable difference was that the Moderate subgroup elevated on 
scales 4,6, 7 and 8 but did not elevate on their RC counterparts. These differences may be 
because, like scale 3, items related to somatization on clinical scales 4, 6, 7 and 8 are now part of 
RC1. This may demonstrate an ability of the MMPI-2-RF to capture the main components of 
somatization on one scale. Similarly, items related to the component “demoralization” were 
removed from these scales and located in RCd (Tallegen et al., 2003). According to Tallegen et 
al (2008) demoralization was an important component of all clinical scales, so for the RC scales 
these items were removed from the individual scales and combined to form the new RCd scale, 
suggesting that RCd captures a core element of people with psychopathology. Thus the fact that 
RCd was elevated by the Moderate subgroup when this was profiled by the MMPI-2-RF may 
demonstrate that an important characteristic of this profile is demoralization. 
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Interpretation of Profiles 
Triad/Somatic Profile 
 The Triad or Somatic configurations are classically associated with somatization (for 
review see Graham, 2006, Deardorff, 2000, Robinson, 2000; Tallegen et al., 2003). Patients with 
this profile are vulnerable to developing physical symptoms in response to stress. They seek 
medical explanations for their problems and lack insight into the psychological factors that may 
underlie or influence the problems (Graham, 2006). Individuals with this profile may also 
manifest depression as episodes of tension, distress, and complaints about weakness and fatigue 
(Friedman et al., 2001). Somatization is also classically associated with medically unexplained 
symptoms, poorer response to treatment, and future development of disability (Graham, 2006).  
Therefore, in general, pain patients with Triad/Somatic profiles have maladaptive trait or coping 
styles that in the present subgroups may be responsible for the limited recovery seen at least six 
months after the injury.  
It is important to note that the present investigation does not differentiate between the 
Triad and the previously reported conversion V profiles differentiated by Graham(2006). 
Although scales 1 and 3 were higher than scale 2 in the current study (see Figure 5), which 
defines the conversion V profile, these were in the same descriptive range (i.e. Very High 
scores). As discussed by several authors, the major difference between the Triad profile and the 
conversion V profile is that the first may represent patients who are experiencing depression 
secondary to adjustment to significant pain symptomology (Graham, 2006). However, this 
differentiation has to be used with caution because as Keller and Butcher (1991) suggested, 
while somatizizers consistently endorse items reflecting somatic distress, they may be more 
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variably endorsing depressive items. Thus, regardless of how they are labeled, the main 
psychological problem of this subgroup is somatization.   
 Moderate/Depressed Profiles 
The interpretation of the Moderate/Depressed profiles is more difficult than the 
Triad/Somatic profile because these had not been identified by previous investigations. 
Moderate/Depressed profiles should certainly be associated with higher levels of psychological 
overlay than the somatic subgroups because they report high elevations in more number of scales 
including scales that measure depression, anxiety, and demoralization, among others. However, 
these profiles are also characterized by elevations on FBS/FBS-r suggesting that these patients 
also exaggerate some symptoms. Elevations on FBS suggest that there is exaggeration of 
physical and cognitive symptoms; a type of exaggeration that is not captured by the other over-
reporting scales. As mentioned by Lees-Haley et al. (1991) FBS was created to detect 
exaggeration of somatic and/or non-psychotic symptoms whereas the other over-reporting scales 
(F,Fb and Fp) collectively termed F family, may be more sensitive to rare psychotic or other 
rarely endorsed psychological symptoms. Exaggeration of symptoms is supported by the 
important number of known malingerers that were classified in the Moderate/Depressed (~ 
35%), suggesting that a significant number of these patients also purposefully underperformed 
and/or exaggerated symptoms on other psychological measures. Therefore, patients with 
Moderate/Depressed configurations may have important and diverse psychological problems and 
exaggerated non-psychotic symptoms.  
Pathological Profiles 
Several studies have interpreted Pathological profiles (e.g., Riley, 1995; Block & 
Ohmeiss, 2004, Gatchel et al., 2006). Research has shown that patients with this profile suffer 
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from severe psychopathologies (Costello, 1997). These investigations have suggested that their 
very high scores demonstrate severe pre-morbid psychological issues (Graham, 2006) and fewer 
resources to cope with physical symptoms compared to those with Normal or Triad profiles 
(Riley, 1995). In a recent study, subjects with Pathological profiles were six times more likely to 
have an Axis 1 clinical disorder (such as major depressive or anxiety disorders) and three times 
more likely to have an Axis II personality disorder compared to those with Triad profiles 
(Gatchel, et al., 2006). 
However, and perhaps more importantly, the present Pathological subgroup also 
demonstrated elevations on all of the over-reporting validity scales, a finding that was not 
described or discussed by previous investigators. These elevations demonstrate that patients with 
Pathological profile exaggerate a multiple array of symptoms. In fact, the majority of these 
patients were known malingerers (~ 65%), indicating that patients with Pathological profiles are 
likely intentionally exaggerating these symptoms. Thus, significant concerns regarding validity 
of the report should be raised when patients present Pathological profiles in medico-legal pain 
evaluations.   
Summary 
The two-cluster solution was considered the best solution when it was used the traditional 
method (Method 1). However, the three-cluster solution was considered the most comprehensive 
in the methods that used the most complete set of scales (i.e. Method 2 and Method 3). Thus, the 
three-cluster solution is considered the most adequate solution when using the MMPI-2 or 
MMPI-2-RF to differentiate patients with financial compensation seen in medico-legal settings. 
There was significant patient overlap between the MMPI-2 and the MMPI-2-RF 
subgroups/clusters. However, in general, the MMPI-2-RF seems to be simpler than its original 
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counterpart in terms of capturing pain related problems by combining somatization into one scale 
and by increasing scale distinctiveness when removing demoralization. Yet, much research is 
needed in this area in order to determine if because of this simplification important pain related 
information is lost. In general, the MMPI-2/MMPI-2-RF three-cluster solutions described a 
Triad/Somatic, Moderate/Depressed and Pathological profiles. Subjects with Triad/Somatic 
profiles are shown to have a tendency to express psychological problems or stress in physical 
symptoms and complains. Patients with Moderate/Depressed profiles are expected to have more 
diverse and moderate psychological problems that may be related to exaggeration of non-
psychotic symptoms. Finally, those with Pathological profiles have diverse and severe 
psychological problems that are due, for the most part, to malingering.  
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CHAPTER VII 
Factors Related to Subgroup Membership 
Injury Severity 
For each method, differences between the resulting subgroups were compared on several 
important variables. Results showed that subgroup membership was not conditioned to any 
spine- related organic factor. Thus, differences in MMPI reporting were not due to organic 
changes consistent with several investigations (e.g. Schade, Semmer, Main, Hora, & Boos, 
1999). Instead, elevated profiles were related to malingering status and a variety of other socio-
demographic variables, including low education, ethnic diversity and legal status. The following 
sections provide some discussion about the relationship between group membership and these 
external variables.  
Malingering Status  
This study demonstrated an exponential increase in the number of malingerers with 
profile elevations. That is, the number of malingerers increased from 15% in the Triad/Somatic 
to 30% in the  Moderate/Depressed subgroups and to  65% in the Pathological subgroups.  Odd 
ratio analysis also indicated that if a patient has a Pathological profile he/she is about 30 times 
more likely to be malingering than a patient with Triad/Somatic profile; and about 7 times more 
likely than a patient with a Moderate/Depressed profile. Similarly, a patient with 
Moderate/Depressed profiles is about 3.5 times more likely to be malingering than a patient that 
presents a Triad/Somatic profile. Thus, the more elevated the MMPI profile the greater should be 
the concern regarding the motivation of the individual to report their symptoms.  
This dose response relationship also supported two fundamental assumptions in 
malingering research. First, that methods to assess psychological abilities and problems are 
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vulnerable to intentional exaggeration (Bush et al., 2005).Second, the more inconsistencies a 
patient presents across multiple or relatively independent domains (i.e. cognitive, physical, 
emotional), the more likely it is that his/her performance reflects deliberate efforts to 
misrepresent their symptoms on a self-report measure (Bianchini et al., 2005; Larrabee, 
Greiffenstein, Greve, & Bianchini, 2007).  
In addition, it is important to note that physical findings, symptom report or type/number 
of surgeries were not related to invalid symptom presentation on the MMPI, and thus 
malingering status. This supported the assertions that persons with confirmed spine pathology 
can and sometimes do malinger (Bianchini and Greve, 2009) and constrated the view of Bogduk 
(2004)  which indicated that a diagnosis of malingering “can be refuted if a genuine source of 
pain can be established” (p. 409). These results are also consistent with Bianchini and Greve 
(2009), which reported definite malingering in patients with objective physical findings who had, 
in fact, had surgery. Thus,  even willingness to undergo invasive procedures such as spinal 
surgery should not rule out malingering (Bianchini, Curtis, & Greve, 2006). 
Obviously, malingering was not caused by the physical injury which has become the 
subject of the legal claim of these patients. However, malingering was shown to co-exist with 
other psychosocial factors and these psychosocial factors can certainly exist in the absence of 
malingering. The next sections explain these factors’ relation to elevated MMPI profiles and to 
symptom exaggeration/malingering. 
Education and Ethnicity   
Analyzing the nature of the relationship between ethnicity and education with elevated 
MMPI profiles (i.e. Moderate/Depressed and Pathological profiles) is complicated by a large 
number of confounding variables. While it is certainly possible that there is a direct relationship 
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between education and ethnicity on symptom report, it is also possible that other related 
variables are indirectly involved. For instance, patient differences in pre-morbid cognitive and 
emotional functions, stress regulation, as well as their financial needs- all variables that have 
shown to be highly correlated with low education and ethnic diversity -are shown to play 
significant role in the manifestation of symptoms and the ability to cope with difficulties (Guillen 
et al., 2010; Kirmayer, Groleau, Looper & Dao, 2004). Thus, it is still not clear at this point 
exactly how low education and ethnicity influence MMPI pain reporting. 
Nevertheless, results from this and other investigations suggest that education and 
ethnicity may be highly associated with exaggerated report of symptoms (e.g. Binder, Kelly, 
Villanueva, & Winslow, 2003; Salazar, Lu, wen & Boone,  2007l; Victor & Boone, 2007) 
although not necessarily with malingering (Salazar, Lu, wen & Boone,  2007; victor & Boone, 
2007 ). One potential explanation is that persons with lower education and minorities may 
employ less sophisticated exaggeration strategies, making them easier to distinguish from real 
injury profiles (Franzen & Martin, 1996). Another explanation is that education and ethnicity are 
highly linked to low socio-economic status which may increase the decision to exaggerate 
symptoms. Socioeconomic status may affect the perception of a particular settlement or 
disability payment, with low socio-economic status perceiving a higher relative gain (Tait, 
Chibnall, Andresen & Hadler, 2006). Adding to this, sufferers with low economical resources 
may view a settlement and/or disability payments as essential for basic support due to having 
fewer alternatives such as post-injury employment (Boyer et al., 2009).   
Non Work- Related Claims 
Interestingly, results from this investigation suggested that Moderate/Depressive profiles 
are linked to claims that are non-work (e.g., personal injury) related. Specifically, the 
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Moderate/Depressed subgroups were 1.3 to 3.3 less likely to be involved in workers 
compensation claims than the other subgroups. One reason for these results may be a positive 
relationship between non-working legal status and symptom report (Rosomoff, 1995). A 
potential explanation is that those with non-work claims are more likely to be sophisticated 
malingerers (since malingering was not related to non-working claims). Patients in non-working 
claims may have more law suit opportunities making them more familiar with malingering 
indicators (Lanyon & Almer, 2002). Patients in non-work claims may also be more often 
coached than those in working claims as they are more likely to have an active attorney present 
on their case (Gunstad & Suhr, 2001). Reports have suggested that many validity scales are 
vulnerable to  familiarity and coaching (eg., Dunn, Shear, Howe & Ris, 2003; Gunstad & Suhr, 
2001; Powell,Gfeller, Hendricks & Sharland, 2004; Rose,Hall, Szalda & Bach, 1998) including 
reports that show that the “F family” scales do not differentiate those with real injuries from 
those that are properly coached (Storm & Graham, 2000). This may explain why those with 
Moderate/Depressed profiles do not elevate on the F family scales. However, neither coaching 
nor number of litigations were assessed in this study, and thus, the actual relationship could not 
be determined.  
Outcome 
Results from this investigation show that subgroup membership was an important 
predictor of scores in current pain reports and outcome measures. Specifically, the Triad/Somatic 
subgroups had the best scores in current pain, catastrophizing and perceived disability, the 
Moderate/Depressed subgroups had worst outcome scores than the Triad/ Somatic profile, but 
better than the Pathological subgroup, a subgroup that reported the highest scores on the 
outcome measures. Consequently, it can be inferred that those with Triad/Somatic profiles would 
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have best recovery from a spine injury followed by those with Moderate/Depressed and then the 
Pathological profiles. These results are consistent with several other investigations (e.g. Block & 
Ohnmeiss, 2000; den Boer, Oostendorp, Beems, Munneke, & Evers, 2006; Kidner, Gatchel, & 
Mayer, 2010) that have demonstrated that MMPI-2 profile elevations are associated with 
increasing pain perception, disability and with poorer outcome from traditional and unilateral 
treatment interventions.   
However, there are some important issues that need to be taken into consideration when 
associating outcome to MMPI profile. First, while the Triad/Somatic profiles had best predictive 
outcome scores in this study, this is not to say that patients with this profile had “good” 
outcomes. In fact, previous investigations have shown that patients with Triad profiles have the 
tendency to report high levels of catastrophizing , take long disability times (Asmundson, & 
Carleton , 2009; Bigos et al., 1991; Vendrig & Lousberg,1997)   and not recover properly from 
surgery (Block, Gatchel, Deardorff, & Guyer, 2003)  when compared to normal profiles. Second, 
due to large exaggeration report and/or malingering in both the Moderate/Depressed and the 
Pathological subgroups it is difficult to infer if outcome report is due to the injury or incentives. 
Indeed, the magnitude of outcome is a central forensic issue in that how disabled or how 
impaired a person is or claims to be dramatically affects the monetary value of his or her claim 
(Bianchini et al., 2005). In this view, subjects are as or more likely to exaggerate their outcome 
report as well as their pain or symptom complaints.   
Summary 
Subgroup membership was not conditioned to any spine related organic factor. Instead, 
malingering status had a strong dose-response relationship with subgroup profile elevations 
suggesting that the more elevated the MMPI profile the greater the chance that an individual is 
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malingering.  Education, ethnic background and legal status were also different among pain 
subgroups. However, while these psychosocial factors can certainly influence symptom 
perception in the absence of malingering, these may also increase the likelihood of symptom 
exaggeration. Lastly, there was a dose-response relationship between perceived outcome and 
MMPI subgroup profile elevation, suggesting that the more elevated MMPI-2 profile is the less 
likely the patient is to recover properly from spine injuries.  
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CHAPTER VIII 
Implications 
In this study, psychological factors and non- organic factors were responsible for 
symptom report and, in turn, responsible for perceived outcome.  This is consistent with the 
abundance of scientific/empirical evidence demonstrating that psychological factors, and not 
physical characteristics of spine injuries, explain the presence of pain symptoms or disability in 
medico-legal chronic pain patients (Gatchel & Kishino, 2011; Saastamoinen, Laaksonen, Leino-
Arjas & Lahelma, 2009). As a result, failure to examine psychosocial issues in pain patients may 
lead to inappropriate conclusions regarding causality and severity of symptoms, as well as ability 
to return to work or recover from surgery (Gatchel et al., 2006; Gatchel & Kishino, 2011). 
Moreover, this study demonstrated a strong relationship between malingering and 
subgroup membership above and beyond physical findings/surgery. Since malingering can lead 
to diverse and severe symptom complaints, it can largely affect decisions and conclusions 
regarding the presence, nature, cause, treatment, and functional implications of pain-related 
disability (Aronoff et al., 2007). As a result, before any questions regarding pain- related 
disability can be addressed, the information obtained from a psychological assessment of validity 
/ malingering must be rigorously examined. As stated in a recent position paper from the 
National Academy of Neuropsychology, “Adequate assessment of response validity is essential 
in order to maximize confidence in the results of neurocognitive and personality measures and in 
the diagnoses and recommendations that are based on the results” (Bush et al., 2005, p. 419). 
Results from this study further support the importance of pre-surgical/procedure 
psychological screenings. Block et al. (2003) have argued that pre-surgical psychological 
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screening is an essential component in the medical diagnostic process of spine surgery 
candidates, especially when the major goal is pain reduction and improved functionality. 
However, it is also important that psychological pre-surgical/procedure screenings take into 
consideration the psychosocial factors related to high- risk profiles in this study (i.e. education, 
ethnicity, legal status, malingering). A psychological pre-surgical/procedure screening that 
considers these factors may be able to answer the questions related to not only whether a certain 
case is likely to have a poor outcome but also whether psychosocial problem(s) influence the 
compensable injury and whether those factors contribute in a meaningful way to the patient’s 
alleged disability. 
Similarly, the present study may be used as a guide in active pain management programs 
after malingering has been ruled out. That is, by identifying those patients with high risk profiles, 
conservative or functional interventions such as cognitive behavioral interventions may be 
recommended as more adequate than relatively independent physical treatments (Gatchel & 
Okifuli, 2006).  
Limitations and Future Studies 
There are some limitations to this investigation. One limitation is that the current sample 
may not be representative of all spine pain patients.  This sample was composed of patients with 
chronic pain (patients that have not recovered six months after the injury), a type of pain episode 
that has been linked to emotional distress (Turk & Melzack, 2003). This explains why this study 
did not find a profile with no psychological overlay or Normal profile. Although another 
possibility for not finding this profile might be that all those with monetary compensation have 
elevated MMPI profiles (Rohling, Binder & Langhinrichsen-Rohling, 1995; Meyers et al., 2002). 
Therefore, in order to better clarify the role of spine injury on symptom report, future cluster 
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analysis investigation should also include medico-legal patients with acute or recurrent pain 
episodes.   
Another limitation is that the current study only used self-report measures of outcome, 
instead of practical measures of outcome such as length of return to work or surgery recovery.  
Future studies may increase the predictive validity of the current findings by evaluating these 
practical outcome variables in patients that present the above profiles. Future studies could also 
identify how low-socioeconomic and legal statuses influence MMPI pain symptom and 
malingering report – specifically, how non-malingering spine patients with different 
socioeconomic and legal statuses perform on psychological measures. Finally, it is important to 
conduct similar cluster analytic studies on other psychological measures (i.e. Personality 
Assessment Inventory, Millon Clinical Multiaxial Inventory) as they might provide further 
insight on the emotional similarities/differences of spine pain subgroups. 
CONCLUSION 
This study expands on previous cluster analytic investigations by better describing the 
physical, psychological, and socio-legal factors that influence MMPI-2 and MMPI-2-RF based 
subgroups of spine pain patients. The present study also illustrates the clinical circumstances that 
can influence a given patient (based on their MMPI profile) to recover from a spine injury, 
specifically those patients that are seen in medico-legal contexts. As a result, the current study is 
relevant for informing decisions regarding possible physical interventions including pre-surgical 
screening and choosing between conservative and more invasive physical interventions. 
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APPENDIXES 
Appendix A: Common Physical Impairments that Cause Spine Pain 
 Muscle Ligament Injuries are relatively common consequences of strenuous physical 
activity. Sprains are injuries involving ligaments. Sprains are usually caused by trauma that 
displaces a joint resulting in stretching or tearing of the associated ligament(s).  
 In disc bulge and herniation, pain that may result directly from the annulus tears, from 
irritation caused by the release of chemicals from the nucleus, or by compression of the nerve 
root.  
 Myofascial pain syndrome refers to musculoskeletal pain arising from localized trigger 
points in a rigid band of muscle. These focal trigger points are tender to palpation may cause 
muscle weakness or reduced range of motion.  
 Radiculopathy /Sciatica refers to a disruption of (or near) the nerve root that can result in 
pain as well as sensory or motor disturbances. An important feature of radiculopathy is that 
symptoms are often referred to the limb associated with the disrupted nerve.  
 Spinal Stenosis refers to a narrowing of the spinal canal, nerve root canal, or foraminal 
openings from which nerve roots exit the canal. Symptoms typically occur when these nerve 
fibers become impinged.  
 Spondylolysis refers to a stress fracture of the pars interarticularis, the narrow bridge 
between the upper and lower facet joint of a vertebrae. A condition known as spondylolisthesis 
can occur if the fracture is bilateral and the vertebrae slip out of alignment. When pain is present 
it is thought to be caused by nerve root compression, intervetebral disc pain, or facet joint pain. 
 Spondylosis is a condition caused by age-related disc degeneration that causes a number 
of pathological processes that can ultimately result in a narrowing of the spinal canal.  
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 Whiplash-associated disorder (WAD) refers to a collection of symptoms resulting from 
rapid hyperextension/flexion of the neck, often associated with motor vehicle accidents.  
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Appendix B:The Pain Disability Index
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Appendix C: Pain Chatastrophizing Scale 
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Appendix D: Malingering Classification Method 
 Determination of malingering status (i.e. MPRDa and MPRDb) was based on the criteria 
proposed by Bianchini et al., (2005). Classification relied on performance on psychometric 
indicators and examination of available records. 
 Psychometric indicators. The cutoffs for the indicators used for MPRD classification 
were based on examination of classification accuracy data derived from published criterion- 
groups’ validation (known-groups) traumatic brain injury studies and in consideration of the 
general literature on specific indicators. In all cases, the cutting scores were based on the 
performance of patients seen for neuropsychological evaluation for claims of brain injury and the 
samples included patients with objectively documented brain pathology.  
 Classification accuracy data for the psychometric indicators used in this study were 
obtained from: 1) Test of Memory Malingering (TOMM, Tombaugh, 1996) data from Greve, 
Bianchini, and Doane (2006); 2) Portland Digit Recognition Test (PDRT; Binder, 1993) data 
from Greve and Bianchini (2006); 3) Word Memory Test (WMT; Green 2005; Green Allen & 
Astner, 1996) data from Greve, Ord, Curtis, Bianchini, and Brennan (2008); 4) Reliable Digit 
Span, Digit Span, Working Memory and Processing Speed Indexes from the Wechsler Adult 
Intelligence Scale –III (WAIS-III; Wechsler, 1997) data from Etherton, Bianchini, Heinly, & 
Greve (2006ab), Etherton, Bianchini, Ciota, Heinly, and Greve (2006), and Heinly et al., (2005)  
; 5) Recognition Hits raw score data were from the California Verbal Learning Test (CVLT; 
Delis, Kramer, Kaplan, & Ober, 1987, 2000) data of Curtis, Greve, Bianchini, and Brennan 
(2006); 6) Millon Clinical Multiaxial Inventory-III (MCMI-III; Millon, 1994) data from 
Aguerrevere, Greve, Bianchini and Ord (under review). 8) F, Fb, Fp and Symptom Validity 
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Scale (FBS; Lees-Haley, English, & Glenn, 1991) from the MMPI-2 TBI data of Greve, 
Bianchini, Love, Brennan, and Heinly (2006). Regarding the CVLT, data showed that the 
classification accuracy of Recognition Hits is equally accurate in CVLT-1 and CVLT-2 at the 
selected cutoffs (Greve, Curtis, Bianchini, & Ord, 2009). 
Selected Cutoffs. Table A presents the data on the classification accuracy of the selected 
cutoffs for each indicator. Also reported in Table A is Positive Predictive Power (+PP) for the 
weakest value that were considered positive for each variable and Negative Predictive Power (-
PP) for the weakest variable values that were considered negative. The predictive values were 
derived using a hypothetical malingering baserate of 35% (based on Mittenberg, Patton, 
Canyock, & Condit, 2002). +PP and -PP provide a concrete index of confidence that a patient is 
malingering or not malingering, respectively. Application of this system results in each score 
being classified as 1) a negative indication of response bias or malingering; 2) an ambiguous 
indication of response bias or malingering; or, 3) a positive indication of response bias or 
malingering.  
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Table A  
Cutoffs and Malingering Indicators for MPRDa and MPRDb 
Indicator  Negative -PP Ambiguous Positive +PP
Test of Memory Malingering 
Trial 2  50-49 .82 48-45 44-0 .85 
Retention  50-49 .83 48-45 44-0 .91 
Portland Digit Recognition Test 
Easy  36-28 .86 27-23 22-0 .97 
Hard  36-23 .86 22-18 17-0 .93 
Total  72-50 .88 49-45 44-0 .95 
Word Memory Test 
IR  100-80 .83 78.5-72.5* 70-0 .86 
DR  100-80 .83 78.5-72.5* 70-0 .85 
CNS1  100-75 .83 72.5-57.5* 55-0 .88 
Wechsler Adult Intelligence Scale 
RDS  17-8 .87 7 6-0 .84 
DS  30-8 .85 7-5 4-0 1.00
WMI  155-81 .88 80-76 75-45 .86 
PSI  155-76 .84 75-71 70-45 .89 
California Verbal Learning Test 
Rec Hits  16-12 .82 11-10 9-0 .91 
Millon Multiaxial Clinical Inventory-III
Disclosure  0-55 .85 56-70 71-115 .84 
Debasement  0-65 .86 66-70 71-115 .88 
Desirability  115-60 .77 59-55   54-0 .87 
Minnesota Multiphasic Personality Inventory-II (only for MPRDb)
F  0-65 .82 66-80 81-130  
Fb  0-65 .80 66-85 81-130  
Fp  0-65 .73 66-80 81-130  
FBS(raw)  0-24 .84 24-28 29-32  
 
*The WMT scores are recorded in increments of 2.5% so scores between 80 and 78.5 and 
between 72.5 and 70 are not possible. 
-PP = Negative Predictive Power, the minimum probability that a negative score was 
produced by a non-malingering case assuming a malingering baserate of .35; +PP = Positive 
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Predictive Power, the minimum probability that a positive score was produced by a .malingering 
case assuming a malingering baserate of .35; CN1 = consistency of recall between IR and DR 
from the Word Memory Test; DR = delayed recall trial from the Word Memory Test; DS = Digit 
Span scales score; IR = immediate recall trial from the Word Memory Test; PSI = Processing 
Speed Index; Rec Hits = Recognition Hits from the California Verbal Learning Test; WMI = 
Working Memory Index. 
Significantly Below Chance Performance. A statistically significantly below-chance result on 
a forced-choice SVT is definitive evidence of intentional exaggeration of cognitive deficits 
(Bianchini et al., 2001; Frederick & Speed, 2007; Reynolds, 1998). This has been recognized in 
both published systems for diagnosing malingering (Bianchini et al., 2005; Slick, Sherman, & 
Iverson, 1999). A below chance result “is not a random or chance occurrence but represents a 
purposive distortion by the examinee” (Reynolds, 1998; p. 272; emphasis added). In this study, 
below chance results were possible on the PDRT, TOMM and/or WMT. For the TOMM, two 
tests a score of 17/50 or less was considered significantly below chance (below the lower bound 
of the 95% confidence interval around a score of 25/50). For the PDRT, scores of 11/36 on Easy 
and Hard, and 27/72 on Total were considered significantly below chance. For the WMT, below 
chance was 13/40 on Immediate and Delayed Recognition. 
 Qualitative Inconsistencies. Four kinds of inconsistencies were considered as part of the 
MPRD classification: 1) non-organic or functional findings on physical examination (exclusive 
of Functional Capacity Evaluation [FCE]); 2) an inconsistency between the patient’s behavior 
during examination and their behavior when they do not believe they are being observed; 3) 
inconsistencies between the patient’s subjective report of symptoms or history and their 
documented history; and, 4) evidence of submaximal effort, symptom magnification, or non-
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organic / function findings on a formal FCE. Multiple inconsistencies are required to contribute 
to a diagnosis of MPRD to account for their qualitative nature.  
 Operationalization of MPRD. The operationalization of the MPRD criteria results in a 
given score being considered positive, negative, or indeterminate (neither clearly positive nor 
negative). Moreover, because at least two qualitative inconsistencies are required to reach at least 
the Possible designation, patients with only one inconsistency are not clearly classifiable. Thus, 
the cases who do not meet criteria for an MPRD diagnosis were further divided into three 
groups: 1) those with no positive psychometric findings or inconsistencies; 2) those with no more 
than one ambiguous psychometric finding and no inconsistencies; 3) those with two or more 
ambiguous psychometric findings and/or only one inconsistency. In summary, using the above 
described system, patients were initially placed into one of the following six groups:1) negative 
on all indicators used.2) a single ambiguous finding with no qualitative inconsistencies present 
and otherwise negative.3) more than one ambiguous psychometric finding but no positive 
psychometric findings or a single inconsistency.4) at least one positive psychometric finding or 
one or more inconsistencies but did not meet full criteria for malingering.5) met criteria for 
probable malingering.6) met criteria for definite malingering. 
 For purpose of this study, patients in groups 2 and 3 were combined into a single 
Incentive-Only group. The group 4 cases were referred to as Indeterminate while groups 5, 6, 
and 7, were called Possible, Probable, and Definite MPRD, respectively. See Table B  
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Table B  
Group Initial Malingering Classification 
1 negative on all indicators 
2 only one ambiguous finding 
  
3 more than one ambiguous finding but no positive findings 
  
4 at least one positive finding but does not meet criteria for 
malingering 
  
5 meets criteria for Probable MPRD 
6 meets criteria for Definite MPRD 
  
  Final Malingering Classification 
 Not Malingering (groups 1 and 2) 
 Indeterminate (group 3) 
 Possible MPRD (group 4) 
 Probable MPRD (group 5) 
 Definite MPRD (group 6) 
  All MPRD (groups 5 and 6) 
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